Thrombocytopenia, unspecified

D3_THROMBOCYTOPENIANAS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D69.6 Hospital discharge: ICD-9 — 2875 Hospital discharge: ICD-8 — 28719\|2872 Cause of death: ICD-10 — D69.6 Cause of death: ICD-9 — 2875 Cause of death: ICD-8 — 28719\|2872 2 out of 7 registries used, show all original rules.	3522
4. Check minimum number of events None	3522
5. Include endpoints None	3522
6. Filter based on genotype QC (FinnGen only)	2962

Control definitions (FinnGen only)

Control exclude: D3_COAGDEF_PURPUR_HAEMORRHAGIC

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D69
Name in latin: Thrombocytopenia NAS

NAME	D3_THROMBOCYTOPENIANAS
CONTROL_EXCLUDE	D3_COAGDEF_PURPUR_HAEMORRHAGIC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D696
HD_ICD_9	2875
HD_ICD_8	28719\|2872
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D696
COD_ICD_9	2875
COD_ICD_8	28719\|2872
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Thrombocytopenia, unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	20979	9790	11000
Only index persons	17647	8393	9254
Unadjusted period prevalence (%)
Whole population	0.29	0.28	0.31
Only index persons	0.33	0.31	0.35
Median age at first event (years)
Whole population	60.24	59.26	61.06
Only index persons	59.45	57.70	61.04

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2962	1375	1587
Unadjusted period prevalence (%)	0.62	0.49	0.73
Median age at first event (years)	62.76	58.01	66.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3071: Matched controls
30705

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

16264.3

307.7

2914

D64.9

ICD-10 Finland

Anaemia, unspecified

5.3

307.7

876

2144

XW000

NOMESCO Finland

Bone marrow biopsy

23.6

307.7

943

567

D70.89

ICD-10 Finland

Neutropenic splenomegaly

22.8

307.7

270

129

WW500

NOMESCO Finland

Blood transfusion

14.4

307.7

636

546

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

10.0

307.7

551

658

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

7644.4

307.7

625

D70.82

ICD-10 Finland

Drug-induced neutropenia

21.5

307.7

300

154

L03AA02

ATC

filgrastim; parenteral

9.0

240.2

311

379

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

10.4

232.8

269

282

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

6.8

228.3

384

630

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.0

223.0

816

2576

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

79.1

200.3

107

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.9

195.7

708

2200

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

12.3

185.4

188

162

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

15.2

181.0

161

111

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

875.5

170.6

166

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

6.0

168.0

314

568

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

11.7

156.5

163

146

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

27.3

143.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

140.3

1885

11642

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

10.1

138.1

160

167

R50.9

ICD-10 Finland

Fever, unspecified

3.0

137.9

768

3057

JN6AD

NOMESCO Finland

CT of torso and neck

8.9

136.9

175

208

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

25.4

136.8

JN4AD

NOMESCO Finland

Body CT examination

3.3

134.9

623

2223

28719

ICD-8 Finland

Purpura and other haemorrhagic conditions, Thrombocytopenia NUD

+∞

133.3

127

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.6

133.2

504

1586

L03AA14

ATC

lipegfilgrastim; parenteral

8.7

125.0

161

193

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

16.8

123.8

104

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

13.8

120.7

113

ZX120

NOMESCO Finland

Intravenous

3.5

120.2

484

1579

L03AA13

ATC

pegfilgrastim; parenteral

4.9

117.6

274

600

JN4BD

NOMESCO Finland

Extensive body CT

3.2

115.7

528

1858

H02AB06

ATC

prednisolone; systemic

2.4

115.1

1744

10990

YNB10

NOMESCO Finland

Collection of stem cells for transplant

55.3

114.5

M04AA01

ATC

allopurinol; systemic

2.9

114.3

676

2753

H02AB02

ATC

dexamethasone; systemic

3.1

114.1

554

2021

WW300

NOMESCO Finland

Transfer of autologic stem cells

28.2

114.0

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

9.0

112.9

142

165

D69.5

ICD-10 Finland

Secondary thrombocytopenia

380.8

111.1

111

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

12.3

99.8

100

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.5

96.4

194

373

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

96.3

343

1027

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

94.2

759

3568

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

25.0

93.6

Z51.5

ICD-10 Finland

Palliative care

3.0

91.3

460

1701

A04AA02

ATC

granisetron; systemic, transdermal

3.5

91.0

335

1024

D68.8

ICD-10 Finland

Other specified coagulation defects

27.0

89.0

D69.4

ICD-10 Finland

Other primary thrombocytopenia

+∞

87.9

B02BX05

ATC

eltrombopag; oral

+∞

87.9

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

19.8

87.9

A04AA01

ATC

ondansetron; systemic, rectal

3.2

86.9

390

1347

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.0

85.8

190

397

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

84.1

1199

7100

C83.1

ICD-10 Finland

Mantle cell lymphoma

18.5

83.8

A03FA01

ATC

metoclopramide; systemic, rectal

2.3

83.7

837

4301

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.6

83.0

299

900

9989/3-C42.1

ICD-O-3

Myelodysplastic syndrome, NOS, of bone marrow

35.2

82.4

J01MA12

ATC

levofloxacin; systemic

2.3

81.9

754

3735

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

44.3

80.6

C03CA01

ATC

furosemide; systemic

2.1

77.9

1174

7050

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

77.1

1076

6274

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.3

75.5

112

158

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

18.5

72.5

A02BC02

ATC

pantoprazole; systemic

2.1

71.5

2226

17082

ZX108

NOMESCO Finland

Inhalation

11.1

67.8

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

67.6

834

4603

3039, ,

Kela drug reimbursment

+∞

66.9

1517, ,

Kela drug reimbursment

+∞

66.9

6BA02, ,

NOMESCO Finland

22.6

66.9

N02AA05

ATC

oxycodone; systemic

2.2

65.7

737

3915

B03XA02

ATC

darbepoetin alfa; parenteral

5.0

65.5

146

306

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

64.7

1271

8237

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.2

62.9

261

855

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

11.4

61.4

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

16.9

60.0

A41.9

ICD-10 Finland

Sepsis, unspecified

3.7

58.9

193

543

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

58.4

977

5957

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.2

57.8

246

817

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

9.3

57.0

TGC00

NOMESCO Finland

Bronchial lavation

4.4

56.8

148

352

L04AD01

ATC

ciclosporin; systemic

5.7

55.7

106

193

ZXE00

NOMESCO Finland

One hour or less

1.8

55.2

1249

8351

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

54.2

514

2534

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

9.0

53.2

L01CB01

ATC

etoposide; systemic

10.5

52.7

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

9.1

52.0

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

22.6

51.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

50.6

442

2103

R18

ICD-10 Finland

Ascites

4.9

50.4

113

238

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

14.7

50.2

1XC02, ,

NOMESCO Finland

9.0

50.2

2875A

ICD-9 Finland

Purpura and other haemorrhagic conditions, Thrombocytopenia, unspecified

+∞

50.1

127

Kela drug reimbursment

Transplant complication

5.6

48.3

171

H02AB09

ATC

hydrocortisone; systemic

4.2

47.1

127

310

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.5

46.5

170

B01AB10

ATC

tinzaparin; parenteral

2.3

45.1

404

1936

A05AA02

ATC

ursodeoxycholic acid; oral

5.6

45.0

157

ZXD05

NOMESCO Finland

Urgent procedure

1.8

44.8

965

6268

L04AA06

ATC

mycophenolic acid; systemic

4.8

44.5

102

219

R04.0

ICD-10 Finland

Epistaxis

2.5

44.3

316

1372

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

43.7

684

4021

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.0

43.6

202

703

PJA10

NOMESCO Finland

Exploration of lymph nodes

5.9

43.5

134

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

43.2

826

5167

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

43.1

425

2115

D61.9

ICD-10 Finland

Aplastic anaemia, unspecified

62.2

42.3

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.7

42.1

142

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

12.2

41.9

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.6

41.9

101

226

ED1AA

NOMESCO Finland

Mandibular X-ray examination

8.1

41.8

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

13.1

41.7

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

14.2

41.6

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.6

41.3

142

412

XX3DW

NOMESCO Finland

Time consuming IT work

2.2

41.3

401

1983

ZX070

NOMESCO Finland

Intensity modified radiotherapy

4.5

41.2

101

229

A07AA11

ATC

rifaximin; oral

12.6

40.9

L04AX01

ATC

azathioprine; systemic

3.2

40.9

171

561

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.2

40.7

166

536

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

40.7

280

1194

AA1AD

NOMESCO Finland

CT of head and brain

1.7

40.3

983

6574

JMA10

NOMESCO Finland

Transabdominal total splenectomy

9.5

39.8

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

8.2

39.7

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

7.3

39.4

D69.1

ICD-10 Finland

Qualitative platelet defects

138.5

38.8

C03DA01

ATC

spironolactone; oral

2.0

38.5

449

2376

B01AB05

ATC

enoxaparin; parenteral

1.7

38.4

983

6642

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

4.6

37.9

203

ZX112

NOMESCO Finland

Subcutaneous

4.0

37.8

109

280

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.0

37.2

109

283

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

9.5

37.1

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.0

36.9

105

267

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.2

35.6

340

1666

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

11.0

34.7

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

34.6

409

2170

B02AA02

ATC

tranexamic acid; systemic

2.0

34.1

412

2202

WZC30

NOMESCO Finland

Teaching

1.8

34.0

565

3355

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

4.9

34.0

156

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.0

33.7

155

537

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

33.0

301

1446

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

33.0

167

610

H02AB07

ATC

prednisone; oral

1.9

32.9

445

2471

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.6

32.9

112

D64.8

ICD-10 Finland

Other specified anaemias

4.0

32.7

241

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

32.5

628

3895

2873A

ICD-9 Finland

Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]

+∞

32.3

D69.0

ICD-10 Finland

Allergic purpura

34.6

31.9

TK800

NOMESCO Finland

Hemodialysis

3.8

31.9

259

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

7.2

31.8

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

31.8

142

484

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

10.7

31.3

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

4.8

31.3

151

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

30.8

249

1137

122

Kela drug reimbursment

Aplastic anaemia

86.0

30.8

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.8

30.6

164

617

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

30.5

323

1643

N02AX02

ATC

tramadol; systemic, rectal

1.6

30.5

1295

9774

B02BX04

ATC

romiplostim; parenteral

+∞

30.3

A07AA09

ATC

vancomycin; oral

4.4

30.2

172

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

7.0

30.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

30.1

782

5245

Z94.4

ICD-10 Finland

Liver transplant status

10.4

29.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

29.4

1224

9173

R4110

NOMESCO Finland

Physiotherapy

1.6

29.2

851

5868

K92.1

ICD-10 Finland

Melaena

2.4

29.2

208

899

K70.4

ICD-10 Finland

Alcoholic hepatic failure

9.3

29.2

TPX15

NOMESCO Finland

Removal of vascular injection port

8.9

28.9

L04AD02

ATC

tacrolimus; systemic

5.5

28.8

104

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

10.8

28.7

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

28.6

438

2525

UJF32

NOMESCO Finland

Coloscopy

1.6

28.5

808

5527

K72.9

ICD-10 Finland

Hepatic failure, unspecified

7.4

28.4

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

28.4

116

375

Z3231

NOMESCO Finland

Registered nurse

1.6

28.3

837

5784

1516, ,

Kela drug reimbursment

+∞

28.2

3038, ,

Kela drug reimbursment

+∞

28.2

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.7

28.0

SPAT1088

SPAT

Blood transfusion

7.7

28.0

J01DB01

ATC

cefalexin; oral

1.7

28.0

2448

21537

R72

ICD-10 Finland

Abnormality of white blood cells, not elsewhere classified

9.5

28.0

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

27.9

237

1105

J01MA14

ATC

moxifloxacin; systemic

2.1

27.7

301

1544

D75.9

ICD-10 Finland

Disease of blood and blood-forming organs, unspecified

7.6

27.6

D47.1

ICD-10 Finland

Chronic myeloproliferative disease

11.2

27.6

D73.1

ICD-10 Finland

Hypersplenism

47.6

27.4

WW200

NOMESCO Finland

Immunization

3.2

27.4

108

342

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

53.8

27.2

D61.3

ICD-10 Finland

Idiopathic aplastic anaemia

+∞

27.1

3052, ,

Kela drug reimbursment

+∞

27.1

1524, ,

Kela drug reimbursment

+∞

27.1

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

6.3

27.0

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

27.0

275

1377

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.9

26.9

210

A06AD11

ATC

lactulose; oral

1.8

26.9

493

2997

A41.8

ICD-10 Finland

Other specified sepsis

3.5

26.7

272

J05AB11

ATC

valaciclovir; oral

1.8

26.7

440

2592

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

26.4

489

2982

WPA13

NOMESCO Finland

Palliative consultation

7.6

26.3

Z2221

NOMESCO Finland

Medical doctor

1.6

26.3

794

5498

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.3

26.2

216

994

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.5

26.0

N05CF01

ATC

zopiclone; oral

1.6

25.9

948

6859

A46

ICD-10 Finland

Erysipelas

1.8

25.8

479

2919

A02BC01

ATC

omeprazole; systemic

1.6

25.6

805

5622

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

9.5

25.3

JN4CD

NOMESCO Finland

Very extensive body CT

2.7

25.2

141

543

B02BX08

ATC

avatrombopag; systemic

+∞

25.0

C82.1

ICD-10 Finland

Follicular lymphoma grade II

6.4

24.8

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.7

24.3

121

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

4.6

24.3

125

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

24.2

1035

7715

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

5.4

24.0

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

5.1

23.5

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

47.0

23.3

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

7.3

23.3

WX402

NOMESCO Finland

General anaesthesia

1.6

23.2

660

4485

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

5.4

23.2

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

7.4

22.9

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.2

22.9

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

22.8

116

425

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.3

22.7

256

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

27.5

22.2

212

Kela drug reimbursment

Gout

3.2

22.2

275

WX892

NOMESCO Finland

Monitored bed care

2.0

22.1

258

1356

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.0

21.8

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

21.8

232

1179

WX002

NOMESCO Finland

Sedation and analgesia

1.6

21.6

571

3806

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

21.2

531

3491

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

4.7

21.0

103

TAB00

NOMESCO Finland

Lumbar puncture

2.4

21.0

149

643

TNE20

NOMESCO Finland

Bone marrow aspiration, pelvis

16.7

20.9

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

5.4

20.9

ZX131

NOMESCO Finland

Intrathecal

60.4

20.9

A10AB05

ATC

insulin aspart; parenteral

2.0

20.7

253

1349

J01MA02

ATC

ciprofloxacin; systemic

1.5

20.7

1142

8891

TGD00

NOMESCO Finland

Needle biopsy of lung

6.4

20.5

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

8.2

20.5

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.4

20.5

227

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

20.4

112

427

J01FF01

ATC

clindamycin; systemic

1.5

20.4

769

5546

N03AX14

ATC

levetiracetam; systemic

2.8

20.3

106

394

D68.9

ICD-10 Finland

Coagulation defect, unspecified

48.3

20.1

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

5.1

20.0

L01BB02

ATC

mercaptopurine; oral

4.4

19.9

112

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.0

19.8

142

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

19.8

255

1385

K29.6

ICD-10 Finland

Other gastritis

4.1

19.5

135

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

4.6

19.4

102

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

14.7

19.4

J02AC03

ATC

voriconazole; systemic

15.6

19.2

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

15.6

19.2

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

19.2

153

694

L01AX03

ATC

temozolomide; systemic

5.6

19.1

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

19.1

110

430

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

20.2

19.0

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.1

19.0

254

D69.2

ICD-10 Finland

Other nonthrombocytopenic purpura

34.5

18.9

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

18.8

131

561

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

18.7

168

800

JJC00

NOMESCO Finland

Allogenic transplantation of liver

17.2

18.7

ZX121

NOMESCO Finland

Central venous catheter

7.4

18.6

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

18.6

2039

17813

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

4.4

18.5

106

B01AA03

ATC

warfarin; systemic

1.5

18.5

584

4044

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.1

18.5

123

K92.0

ICD-10 Finland

Haematemesis

2.8

18.3

335

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.0

18.3

128

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.4

18.2

189

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

5.3

18.0

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

52.8

17.9

P01BA02

ATC

hydroxychloroquine; oral

1.9

17.8

226

1221

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

17.8

993

7694

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.5

17.5

179

M35.1

ICD-10 Finland

Other overlap syndromes

6.6

17.5

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.5

17.3

171

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

17.3

148

692

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

17.2

790

5896

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.7

17.1

353

N03AX16

ATC

[U] pregabalin

1.5

17.0

626

4470

WF002

NOMESCO Finland

Radical radiotherapy

2.0

17.0

189

976

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

16.9

170

845

Z3226

NOMESCO Finland

Physiotherapist

1.6

16.9

515

3530

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

16.9

1446

12020

J01CA04

ATC

amoxicillin; systemic

1.5

16.6

2342

21148

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

16.5

207

1113

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

7.3

16.5

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

16.4

179

918

B99

ICPC

Blood/lymph/spleen disease other

6.1

16.4

Z31.5

ICD-10 Finland

Genetic counselling

2.2

16.3

142

668

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

16.3

662

4818

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

16.2

405

2651

N02BE01

ATC

paracetamol; systemic, rectal

1.5

16.2

2613

24152

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

3.2

16.0

205

WVA20

NOMESCO Finland

Medicine administration

2.5

16.0

401

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.6

16.0

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

16.0

269

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

21.1

16.0

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

16.0

196

1047

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.0

15.9

232

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.3

15.9

122

545

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

15.9

184

963

A03

ICPC

Fever

1.6

15.7

467

3180

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

15.7

238

1360

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.4

15.7

106

448

9983/3-C42.1

ICD-O-3

Myelodysplastic syndrome with excess blasts of bone marrow

85.5

15.6

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

15.6

253

1476

L04AX03

ATC

methotrexate; systemic

1.8

15.5

267

1584

WX872

NOMESCO Finland

Intensive care

2.0

15.5

163

825

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

15.3

188

1005

C91.4

ICD-10 Finland

Hairy-cell leukaemia

28.7

15.2

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.4

15.0

162

WZC15, ,

NOMESCO Finland

4.2

15.0

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

15.0

300

1853

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

15.0

144

704

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

5.0

15.0

R31

ICD-10 Finland

Unspecified haematuria

1.6

15.0

329

2084

D72.9

ICD-10 Finland

Disorder of white blood cells, unspecified

10.9

15.0

E0000UV, ,

ATC

1.4

14.9

1142

9264

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

14.9

531

3755

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

6.8

14.9

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.6

14.8

338

WPB10

NOMESCO Finland

Making a convalescent care decision

5.5

14.8

C90.0

ICD-10 Finland

Multiple myeloma

3.5

14.7

145

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.7

14.5

295

D61.0

ICD-10 Finland

Constitutional aplastic anaemia

150.7

14.5

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

14.5

294

1825

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

36.2

14.4

9940/3-C42.1

ICD-O-3

Hairy cell leukemia, NOS, of bone marrow

36.2

14.4

WX882

NOMESCO Finland

High dependency care

2.4

14.3

101

435

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

4.2

14.3

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

27.3

14.3

A04AA55

ATC

palonosetron, combinations; systemic

2.3

14.3

104

455

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

4.1

14.2

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.8

14.2

115

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

14.2

279

1716

R60.0

ICD-10 Finland

Localized oedema

1.6

14.2

370

2443

K76.9

ICD-10 Finland

Liver disease, unspecified

3.4

14.1

144

R11

ICD-10 Finland

Nausea and vomiting

1.7

14.1

249

1487

R53

ICD-10 Finland

Malaise and fatigue

1.4

14.0

709

5357

N19

ICD-10 Finland

Unspecified kidney failure

2.1

13.9

130

629

K72.1

ICD-10 Finland

Chronic hepatic failure

15.8

13.9

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

13.9

302

130

Kela drug reimbursment

Malignant tumour

1.7

13.9

274

1687

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

13.8

356

2343

D59.9

ICD-10 Finland

Acquired haemolytic anaemia, unspecified

13.6

13.7

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

13.6

307

1955

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

6.5

13.6

28710

ICD-8 Finland

Purpura and other haemorrhagic conditions, Thrombocytopenia essentialis (Morbus Werlhof)

+∞

13.5

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

13.5

196

1104

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.4

13.5

378

B82

ICPC

Anaemia other/unspecified

2.3

13.5

101

447

Z2446

NOMESCO Finland

Social worker

1.8

13.5

191

1069

WF004

NOMESCO Finland

Palliative radiotherapy

2.6

13.4

307

J05AB01

ATC

aciclovir; systemic

1.4

13.4

578

4235

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

16.3

13.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

13.4

101

449

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

13.4

268

1657

B34.9

ICD-10 Finland

Viral infection, unspecified

2.4

13.4

362

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

25.8

13.4

M31.1

ICD-10 Finland

Thrombotic microangiopathy

25.8

13.4

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

13.3

1009

8136

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

21.2

13.3

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

13.3

447

3119

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

3.7

13.3

116

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

13.3

173

943

C07AB07

ATC

bisoprolol; oral

1.3

13.3

1398

11839

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

13.1

127

624

M10.9

ICD-10 Finland

Gout, unspecified

1.7

13.1

227

1349

WW409

NOMESCO Finland

Other aferesis

12.2

13.1

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.9

13.1

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

13.0

438

3057

306

Kela drug reimbursment

Erythropoietin and darbepoetin

6.1

12.9

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

12.9

175

967

D68.0

ICD-10 Finland

Von Willebrand disease

50.2

12.8

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

12.8

129

644

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.8

12.7

223

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

3.4

12.7

129

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.2

12.7

154

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

5.1

12.7

XX2RW, ,

NOMESCO Finland

3.1

12.7

170

N03AX18

ATC

lacosamide; systemic

4.4

12.6

9811/3-C42.1

ICD-O-3

B lymphoblastic leukemia/lymphoma, NOS, of bone marrow

70.1

12.6

I81

ICD-10 Finland

Portal vein thrombosis

5.5

12.6

ZX080

NOMESCO Finland

Image guided radiotherapy

2.6

12.6

276

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.6

12.4

272

B28

ICPC

Limited function/disability (B)

5.6

12.4

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

5.0

12.4

C07AG02

ATC

carvedilol; oral

1.8

12.4

178

1001

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

12.4

108

510

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

12.4

106

497

K08.3

ICD-10 Finland

Retained dental root

1.7

12.1

224

1354

A28

ICPC

Limited function/disability NOS

1.4

12.0

530

3893

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

12.0

444

3154

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

9.3

12.0

I50.0

ICD-10 Finland

Congestive heart failure

1.7

12.0

234

1437

S97

ICPC

Chronic ulcer skin

1.8

12.0

192

1116

R06.0

ICD-10 Finland

Dyspnoea

1.4

12.0

765

5989

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

12.0

108

517

N05BA04

ATC

oxazepam; oral

1.4

11.9

687

5286

E87.5

ICD-10 Finland

Hyperkalaemia

2.6

11.9

266

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.9

11.9

182

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

10.5

11.7

A06AH03

ATC

naloxegol; oral

2.9

11.7

189

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

11.7

228

1399

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

11.6

616

4673

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

11.6

369

2542

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

19.0

11.6

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

11.5

183

1060

N18.8

ICD-10 Finland

Other chronic renal failure

2.4

11.5

331

K74.3

ICD-10 Finland

Primary biliary cirrhosis

5.0

11.5

B73

ICPC

Leukaemia

13.6

11.4

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.5

11.3

267

SPAT1262

SPAT

Handing over of treatment supplies

1.4

11.3

483

3525

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.0

11.3

128

666

B01AB04

ATC

dalteparin; parenteral

1.9

11.3

137

730

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.3

11.2

360

9961/3-C42.1

ICD-O-3

Primary myelofibrosis of bone marrow

17.1

11.2

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

4.7

11.2

WW402

NOMESCO Finland

Leucoferesis

25.1

11.1

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

20.1

11.1

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

11.1

868

6996

A79

ICPC

Malignancy NOS

2.8

11.1

195

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

8.1

11.1

SPAT1255

SPAT

Intravenous administration of medicine

1.7

11.0

190

1129

AB2

AVR bio, stent

4.4

11.0

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.5

10.9

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

10.9

513

3807

C93.1

ICD-10 Finland

Chronic myelomonocytic leukaemia

43.5

10.9

UKC02

NOMESCO Finland

Cystoscopy

1.4

10.9

474

3469

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

10.9

144

789

K76.7

ICD-10 Finland

Hepatorenal syndrome

11.9

10.8

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.0

10.7

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

10.6

356

P01AB01

ATC

metronidazole; oral, rectal

1.3

10.6

1002

8281

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

10.5

170

992

J05AX18

ATC

letermovir; oral

110.4

10.4

C92.4

ICD-10 Finland

Acute promyelocytic leukaemia [PML]

110.4

10.4

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

5.4

10.4

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.9

10.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

10.4

502

3743

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

10.4

109

553

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

7.7

10.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

10.3

1148

9691

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.2

10.3

127

J02AC04

ATC

posaconazole; systemic

18.8

10.3

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.6

10.2

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

9.6

10.2

9945/3-C42.1

ICD-O-3

Chronic myelomonocytic leukemia, NOS, of bone marrow

23.4

10.2

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

23.4

10.2

H02AB04

ATC

methylprednisolone; systemic

1.5

10.2

360

2530

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

10.1

319

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

10.1

199

1224

UJF92

NOMESCO Finland

Capsular endoscopy

2.4

10.1

270

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

4.5

10.0

R06

ICPC

Nose bleed/epistaxis

2.3

10.0

340

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

3.0

10.0

145

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

14.6

10.0

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.7

10.0

189

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

10.0

319

2198

A10AE04

ATC

insulin glargine; parenteral

1.5

10.0

273

1820

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.6

9.9

230

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.3

9.9

316

6753

FHL

Transabdominal splenectomy

16.7

9.9

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.8

9.9

179

TK810

NOMESCO Finland

Hemofiltration

4.3

9.8

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

2.4

9.8

286

D46.0

ICD-10 Finland

Refractory anaemia without ring sideroblasts, so stated

26.1

9.8

AAA10

NOMESCO Finland

Biopsy through craniotomy

26.1

9.8

WX730

NOMESCO Finland

Conventional respirator

2.7

9.8

191

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

9.8

208

1306

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.8

9.8

133

737

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

9.7

251

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

9.7

206

1294

390

Kela drug reimbursment

Ibrutinib

13.4

9.7

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

9.6

110

575

L04AA01

ATC

[U] ciclosporin

3.1

9.6

127

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.5

9.6

246

B03XA01

ATC

erythropoietin; parenteral

3.4

9.6

R06AE07

ATC

cetirizine; oral

1.3

9.6

1102

9317

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

4.4

9.5

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.0

9.5

133

H05AA02

ATC

teriparatide; parenteral

4.8

9.5

WNF00

NOMESCO Finland

Infection source and contact determination

4.6

9.5

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

9.1

9.5

120

Kela drug reimbursment

Hypogammaglobulinaemia

15.1

9.5

D69.8

ICD-10 Finland

Other specified haemorrhagic conditions

15.1

9.5

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

9.4

157

923

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.2

9.4

113

126

Kela drug reimbursment

Chronic coagulation defects

+∞

9.4

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.1

9.4

436

K76.6

ICD-10 Finland

Portal hypertension

21.7

9.3

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

4.9

9.3

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

9.3

1130

9610

318

Kela drug reimbursment

Teriparatide

4.5

9.3

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.9

9.3

146

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

9.3

424

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.1

9.2

125

L01XX05

ATC

hydroxycarbamide; oral

2.9

9.2

147

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.7

9.1

I50

ICD-10 Finland

Heart failure

2.0

9.1

467

ZXA10

NOMESCO Finland

Bilateral

1.4

9.1

472

3554

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.3

9.1

315

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

9.1

122

673

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

5.0

9.1

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

9.1

140

806

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

9.1

168

1018

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

2.7

9.0

182

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.0

9.0

497

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.3

9.0

101

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

18.6

8.9

D46.1

ICD-10 Finland

Refractory anaemia with ring sideroblasts

24.1

8.9

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.3

8.9

W19

ICD-10 Finland

Unspecified fall

1.5

8.9

266

1809

L01BC06

ATC

capecitabine; oral

1.9

8.8

107

571

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.2

8.8

326

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

2.9

8.8

134

SPAT1263

SPAT

Sampling

1.3

8.8

1083

9209

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

8.8

126

710

R4190

NOMESCO Finland

Nutritional therapy

1.9

8.7

112

609

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

8.7

404

2984

N06AX11

ATC

mirtazapine; oral

1.3

8.7

873

7231

N02AA01

ATC

morphine; systemic, rectal

2.3

8.7

264

A98.5

ICD-10 Finland

Haemorrhagic fever with renal syndrome

2.4

8.7

240

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

2.9

8.6

141

I95.9

ICD-10 Finland

Hypotension, unspecified

2.4

8.6

228

A10AC01

ATC

insulin (human); parenteral

1.6

8.6

200

1283

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

7.6

8.6

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.3

8.6

284

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.3

8.6

S18

ICPC

Laceration/cut

1.3

8.6

1296

11281

ZX100

NOMESCO Finland

Oral

2.7

8.6

164

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.3

8.5

254

ZX114

NOMESCO Finland

Intramuscular

2.7

8.5

159

E83.50

ICD-10 Finland

Hypercalcemia

2.7

8.5

159

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.7

8.5

159

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

8.5

125

710

3AC01, ,

NOMESCO Finland

3.2

8.5

105

WW500, ,

SPAT

27.6

8.5

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

8.5

151

906

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

8.5

142

838

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

7.3

8.4

A02BC05

ATC

esomeprazole; systemic

1.3

8.4

1039

8827

A04AD12

ATC

aprepitant; systemic

2.4

8.4

225

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

8.4

1512

Kela drug reimbursment

Ibrutinib

12.8

8.4

L01AA01

ATC

cyclophosphamide; systemic

4.7

8.3

9689/3-C42.2

ICD-O-3

Splenic marginal zone B-cell lymphoma of spleen

+∞

8.3

D76.1

ICD-10 Finland

Haemophagocytic lymphohistiocytosis

+∞

8.3

A91

ICPC

Abnormal result investigation NOS

1.7

8.3

151

911

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

9.5

8.3

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.1

8.2

342

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.2

8.2

102

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

8.2

274

1905

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

3.0

8.2

118

B02.9

ICD-10 Finland

Zoster without complication

1.6

8.2

186

1189

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

4.8

8.1

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

8.1

343

4622

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

8.1

993

8422

D70

ICD-10 Finland

Agranulocytosis

33.4

8.1

Z85.6

ICD-10 Finland

Personal history of leukaemia

33.4

8.1

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.2

8.1

286

D75.8

ICD-10 Finland

Other specified diseases of blood and blood-forming organs

11.7

8.1

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

22.1

8.0

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

22.1

8.0

L01EL01

ATC

ibrutinib; oral

22.1

8.0

K65.0

ICD-10 Finland

Acute peritonitis

2.9

8.0

125

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

8.0

353

J01AA02

ATC

doxycycline; systemic

1.3

8.0

2119

19588

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

8.0

146

883

B04

ICPC

Blood symptom/complaint

3.9

8.0

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

8.0

775

6386

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

7.2

7.9

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

7.9

456

3490

C09AA05

ATC

ramipril; oral

1.3

7.9

677

5485

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

7.9

146

885

R55

ICD-10 Finland

Syncope and collapse

1.5

7.9

295

2096

M05BA04

ATC

alendronic acid; oral

1.5

7.9

213

1416

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

6.6

7.9

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

4.6

7.9

D07AC01

ATC

betamethasone; topical

1.3

7.8

939

7935

RK320, ,

NOMESCO Finland

3.5

7.8

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

7.8

231

1567

D75.2

ICD-10 Finland

Essential thrombocytosis

3.9

7.7

SPAT1301

SPAT

No procedures

1.3

7.7

810

6738

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.4

7.7

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.4

7.7

204

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

7.6

326

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

18.4

7.6

C95.9

ICD-10 Finland

Leukaemia, unspecified

18.4

7.6

L95.8

ICD-10 Finland

Other vasculitis limited to skin

8.0

7.6

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

25.1

7.6

AA1

Conventional CABG

2.2

7.5

262

N30.0

ICD-10 Finland

Acute cystitis

1.4

7.5

412

3127

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

6.2

7.5

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

3.8

7.5

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

7.5

129

768

H03AA01

ATC

levothyroxine sodium; systemic

1.3

7.4

544

4310

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

7.4

107

605

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

7.4

343

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.8

7.4

125

M05BX04

ATC

denosumab; parenteral

1.6

7.4

159

1002

I85

ICD-10 Finland

Oesophageal varices

80.3

7.4

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

3.5

7.4

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

7.4

277

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

7.4

474

3685

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

3.4

7.4

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

7.4

304

2199

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

7.7

7.4

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

7.4

657

5346

ZXA00

NOMESCO Finland

Right side

1.3

7.4

670

5466

S16

ICPC

Bruise/contusion

1.9

7.4

441

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.6

7.3

160

J47

ICD-10 Finland

Bronchiectasis

2.3

7.3

246

E87.6

ICD-10 Finland

Hypokalaemia

1.8

7.3

528

28799

ICD-8 Finland

Purpura and other haemorrhagic conditions, Other and unspecified

+∞

7.3

B72

ICPC

Hodgkin Lymphoma

10.9

7.3

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

7.3

1072

9255

Z00.8

ICD-10 Finland

Other general examinations

1.5

7.3

194

1287

N17.8

ICD-10 Finland

Other acute renal failure

2.6

7.3

155

D97

ICPC

Liver disease NOS

4.1

7.3

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.2

7.3

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.1

7.2

313

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

7.2

212

1438

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.5

7.2

174

B83

ICPC

Purpura/coagulation defect

30.1

7.1

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.9

7.1

467

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

3.4

7.1

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

4.1

7.1

Z01.7

ICD-10 Finland

Laboratory examination

1.4

7.1

412

3157

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

7.0

313

2295

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

7.0

179

1175

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

8.8

7.0

J12.8

ICD-10 Finland

Other viral pneumonia

3.0

7.0

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.9

7.0

420

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.2

7.0

277

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

7.0

164

1057

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

7.0

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

7.0

629

5122

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.0

7.0

379

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

7.0

207

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.6

7.0

141

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.0

7.0

345

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

7.0

464

A11CC03

ATC

alfacalcidol; systemic

2.0

6.9

339

D70.81

ICD-10 Finland

Neutropenia congenital

13.8

6.9

A02BA03

ATC

famotidine; systemic

1.8

6.9

531

WF003

NOMESCO Finland

Adjuvant radiotherapy

1.9

6.9

452

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.7

6.9

121

726

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

10.9

6.8

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.4

6.8

191

L01XX52

ATC

venetoclax; oral

9.3

6.8

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

6.1

6.8

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.1

6.8

308

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

6.8

217

1498

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

6.7

411

3170

A07AA02

ATC

nystatin; oral

1.6

6.7

141

885

C07AA05

ATC

propranolol; systemic

1.3

6.7

461

3619

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

6.7

348

2619

O28.0

ICD-10 Finland

Abnormal haematological finding on antenatal screening of mother

22.6

6.7

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.4

6.6

193

JAH01

NOMESCO Finland

Laparoscopy

1.8

6.6

567

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.2

6.6

225

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.7

6.6

107

628

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.2

6.6

258

C08CA05

ATC

nifedipine; systemic

1.6

6.6

152

977

K83.0

ICD-10 Finland

Cholangitis

2.3

6.6

194

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.6

6.5

134

836

RK110, ,

NOMESCO Finland

3.4

6.5

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

3.0

6.5

SPAT1229

SPAT

Assessment of need for aid

1.5

6.5

193

1310

RD210, ,

NOMESCO Finland

2.2

6.5

220

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.5

6.5

164

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

6.5

131

815

R05

ICD-10 Finland

Cough

1.3

6.5

536

4314

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.1

6.5

D59.5

ICD-10 Finland

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

70.0

6.4

C83.71

ICD-10 Finland

Burkitt's tumour

70.0

6.4

ZX095

NOMESCO Finland

Combined chemoradiotherapy

3.4

6.4

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

6.4

130

810

B81

ICPC

Anaemia vit B12/folate deficiency

1.7

6.4

100

581

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.4

6.4

178

SPAT1260

SPAT

Consultation of another employee

1.3

6.4

427

3339

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

6.4

262

1896

SPAT1211

SPAT

Application of soft bandage

1.5

6.3

218

1529

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

2.5

6.3

149

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

18.0

6.3

D65

ICD-10 Finland

Disseminated intravascular coagulation [defibrination syndrome]

+∞

6.2

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

26.7

6.2

D02AX

ATC

Other emollients and protectives

1.9

6.2

395

J96.0

ICD-10 Finland

Acute respiratory failure

2.4

6.2

168

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

2.6

6.2

138

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

6.2

130

817

XX9XE

NOMESCO Finland

Other ultrasound examination

3.1

6.2

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.3

6.2

181

L01BA01

ATC

methotrexate; systemic

1.8

6.1

469

WF099

NOMESCO Finland

Other radiotherapy

3.4

6.1

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

6.1

113

687

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

2.8

6.1

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.7

6.1

116

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

6.1

138

884

R4180

NOMESCO Finland

Podiatric therapy

2.4

6.0

158

M32

ICD-10 Finland

Systemic lupus erythematosus

10.0

6.0

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

6.0

225

1600

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

6.0

371

RS220, ,

NOMESCO Finland

2.5

6.0

152

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.5

6.0

152

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

1.9

6.0

350

J94.8

ICD-10 Finland

Other specified pleural conditions

2.2

6.0

202

A04

ICPC

Weakness/tiredness general

1.3

6.0

405

3169

H26.3

ICD-10 Finland

Drug-induced cataract

3.5

6.0

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

617

652

11.59

307.65

2.2

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

850

1661

6.69

307.65

2.2

1.9

1.22

1.36

g/l

0.93

806

1523

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1490

3390

7.59

307.65

8.0

4.1

270.67

245.99

u/l

3.70

1450

3212

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

730

1378

6.64

307.65

2.5

1.8

1.19

1.53

g/l

14.83

625

1199

(21494434) Karyotype in Bone marrow

433

230

21.75

307.65

1.3

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

490

577

9.91

307.65

7.2

5.4

3520.20

631.20

iu/ml

0.48

(3027945) Reticulocytes/Erythrocytes in Blood

1480

3435

7.38

307.65

5.1

2.6

1.96

1.78

5.82

1397

3063

(3045142) Bone marrow Pathology biopsy report

510

298

20.32

307.65

1.7

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

802

1911

5.33

307.65

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

429

259

19.09

307.65

1.2

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

981

2106

6.37

307.65

3.9

2.8

10.10

10.66

g/l

2.37

931

1935

(3023520) Reticulocytes [#/volume] in Blood

1252

2669

7.23

307.65

5.2

2.6

76.43

68.96

e9/l

3.90

949

1963

(3042111) Morphology [Interpretation] in Bone marrow Narrative

791

438

23.97

307.65

2.0

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1017

2874

4.79

307.65

1.7

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

548

795

8.17

307.65

3.5

2.6

3.33

3.61

g/l

3.37

527

756

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

382

449

9.57

305.05

3.6

3.2

18091.15

1463.29

u/ml

0.53

(42870588) Differential panel, method unspecified - Blood

1972

9438

4.04

305.05

13.7

6.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1122

3777

4.10

288.35

1.8

1.7

—

(3019069) Monocytes/Leukocytes in Blood

2307

12867

4.19

271.69

15.0

6.5

9.85

8.96

16.92

2242

12052

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1193

4365

3.83

268.79

3.5

2.0

30.27

29.65

2.46

1164

4243

(3006504) Eosinophils/Leukocytes in Blood

2298

12846

4.13

268.15

14.8

6.4

2.36

2.84

23.19

2237

12021

(3002030) Lymphocytes/Leukocytes in Blood

2320

13120

4.14

264.43

14.9

6.5

27.60

27.27

0.57

2269

12435

(3022096) Basophils/Leukocytes in Blood

2283

12852

4.02

260.02

15.0

6.5

0.61

0.67

4.45

2226

12025

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

236

183

13.88

249.03

2.8

2.3

—

(3011412) CD3 cells [#/volume] in Blood

264

246

11.65

248.21

3.4

2.3

1005.94

1209.38

e6/l

2.05

228

213

(3017181) Myelocytes/Leukocytes in Blood

835

2507

4.20

247.28

8.3

4.3

0.98

0.88

0.53

564

753

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

234

181

13.91

247.26

2.8

2.4

14.88

15.12

0.09

228

175

(1175426) CD3 cells/Lymphocytes in Blood

238

193

13.28

244.44

2.9

2.3

74.33

73.47

0.26

230

179

(3018010) Neutrophils/Leukocytes in Blood

2252

12872

3.81

243.22

13.9

6.3

56.21

57.61

4.90

2207

12289

(3000012) Reticulocyte production index

328

424

8.54

241.54

3.6

2.1

1.00

0.91

1.34

272

293

(3001604) Monocytes [#/volume] in Blood

2355

13911

3.97

240.45

13.8

6.2

0.58

0.60

e9/l

1.76

2136

11840

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1214

4776

3.55

240.14

7.9

3.5

0.79

0.82

mmol/l

8.57

1168

4510

(3006315) Basophils [#/volume] in Blood

2355

13943

3.95

238.83

13.7

6.2

0.03

0.04

e9/l

26.70

2133

11865

(3013115) Eosinophils [#/volume] in Blood

2394

14366

4.02

236.92

14.8

6.4

0.15

0.19

e9/l

40.38

2185

12426

(3019198) Lymphocytes [#/volume] in Blood

2373

14207

3.95

234.48

14.0

6.3

1.62

1.91

e9/l

13.48

2188

12399

(3002179) Metamyelocytes/Leukocytes in Blood

796

2397

4.13

233.52

8.2

4.1

0.85

0.71

1.06

534

722

(46235355) HIV 1 and 2 tests - Meaningful Use set

1156

4498

3.52

231.21

1.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

806

2478

4.05

229.31

2.9

2.7

65.30

66.39

g/l

2.78

763

2285

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

201

142

15.07

223.42

2.1

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

201

142

15.07

223.42

2.1

1.7

—

(3004809) Band form neutrophils/Leukocytes in Blood

326

473

7.59

216.91

6.4

3.4

1.51

1.55

0.06

300

421

(3021440) Promyelocytes/Leukocytes in Blood

775

2408

3.97

216.02

8.4

4.3

0.18

0.11

1.99

500

655

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1086

4272

3.39

210.22

3.4

2.7

26.37

22.59

6.98

1046

3984

(3013650) Neutrophils [#/volume] in Blood by Automated count

2448

15582

3.81

205.72

25.9

9.3

3.54

4.19

e9/l

26.68

2260

13444

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

413

821

5.66

200.85

3.4

2.4

88.33

91.16

1.29

406

799

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2322

14426

3.50

200.08

16.2

6.6

14.50

12.14

umol/l

6.53

2267

13784

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1120

4612

3.25

199.20

3.4

2.7

2.20

2.29

g/l

5.33

1064

4264

(3025159) Blasts/Leukocytes in Blood

752

2433

3.77

195.89

8.9

4.5

0.93

0.09

2.29

476

618

(3022948) Iron [Moles/volume] in Serum or Plasma

1162

4942

3.17

194.82

3.4

2.7

13.90

12.87

umol/l

3.12

1121

4612

(21494814) CD8 cells/Lymphocytes in Specimen

161

17.46

194.28

2.6

2.1

40.09

28.71

7.74

161

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

326

533

6.72

193.65

1.4

1.5

—

(3023368) Bacteria identified in Blood by Culture

1592

8110

3.00

192.74

9.1

4.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

320

524

6.70

189.71

2.7

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

374

739

5.62

182.54

3.6

2.5

196.51

194.06

0.18

365

703

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

385

791

5.42

179.89

2.7

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

296

480

6.72

176.89

1.4

1.5

139.31

144.38

au/ml

0.23

153

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

377

773

5.42

176.44

2.6

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

974

3945

3.15

174.67

9.8

6.3

1.06

1.05

mmol/l

0.75

930

3682

(3024561) Albumin [Mass/volume] in Serum or Plasma

2043

12446

2.92

168.50

9.7

5.2

33.80

35.44

g/l

27.22

1962

11678

(3007164) IgA [Mass/volume] in Serum or Plasma

1164

5334

2.90

165.72

2.2

1.5

2.63

2.49

g/l

0.91

919

3245

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

256

385

7.16

164.03

2.1

1.6

—

(4035726) Immunohistochemistry procedure

679

2328

3.46

158.91

1.8

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

289

513

6.11

157.47

1.3

284.76

251.87

u/ml

0.79

187

292

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

250

392

6.85

153.90

2.0

1.5

—

(3018418) pH of Serum or Plasma

1536

8350

2.68

153.80

8.9

4.2

7.40

7.58

1202

6038

(3037522) Nuclear Ab [Titer] in Serum

875

3563

3.04

152.70

1.6

1.3

673.93

491.63

titre

1.59

224

777

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

745

2775

3.22

151.62

3.3

2.3

0.19

0.21

g/l

10.36

698

2585

(3036489) Thrombin time

401

994

4.49

148.63

3.3

2.2

21.81

21.20

1.05

379

893

(3048929) Epstein Barr virus Ab [Presence] in Serum

363

840

4.77

146.60

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1073

4998

2.76

144.44

2.9

1.9

—

(3033658) Prothrombin time (PT) actual/Normal

1339

6973

2.63

143.88

8.2

4.2

81.89

87.61

12.23

1302

6827

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1993

12609

2.65

141.59

13.2

7.1

1.20

1.21

mmol/l

5.24

1899

11639

(40760892) CBC W Ordered Manual Differential panel - Blood

1187

5912

2.64

138.66

10.9

4.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2130

14044

2.69

136.82

14.6

7.7

1.20

1.21

mmol/l

4.52

1782

12125

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

163

179

9.56

135.49

1.6

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

308

663

5.05

135.36

1.9

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

389

1013

4.25

134.70

3.0

3.5

35.58

73.75

mg/l

1.66

311

862

(3034860) Kappa light chains.free [Mass/volume] in Serum

389

1014

4.25

134.51

3.0

3.5

180.60

55.38

mg/l

0.47

311

862

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

860

3742

2.80

130.06

2.4

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

274

565

5.23

126.37

1.9

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

177

236

7.90

125.81

2.0

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

582

2072

3.23

125.81

2.4

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1373

7613

2.45

124.38

3.0

2.3

3.22

2.81

mg/l

5.61

1254

6554

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

197

8.62

124.29

2.0

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

760

3173

2.85

123.59

5.8

2.8

12.68

8.52

umol/l

3.23

684

2809

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

352

907

4.25

123.25

2.8

3.3

11.03

3.02

ratio

0.63

171

526

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

153

176

9.10

122.65

2.1

1.4

—

(3032080) INR in Blood by Coagulation assay

1985

13034

2.48

122.13

22.1

16.1

1.31

1.28

inr

1.30

1730

10901

(3026493) Urate [Moles/volume] in Serum or Plasma

1313

7215

2.43

120.36

5.3

2.9

339.52

349.86

umol/l

2.52

1224

6332

(3035933) Granulocytes/Leukocytes in Blood

277

604

4.94

119.57

5.6

3.1

56.08

58.01

1.27

277

604

(3023183) Ammonium ion [Moles/volume] in Plasma

285

638

4.82

119.19

5.5

2.7

41.16

36.47

umol/l

1.24

267

573

(3021589) Normoblasts [#/volume] in Blood

1866

12027

2.40

118.00

30.2

11.7

0.01

0.00

e9/l

2.14

1577

9747

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

152

183

8.69

117.51

2.1

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1425

8188

2.38

117.22

2.1

1.7

18.64

20.09

nmol/l

3.63

1302

6927

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

801

3530

2.72

116.56

2.5

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

414

1258

3.65

114.48

2.4

1.9

2.13

1.99

ug/l

0.08

384

1113

(40768795) Lymph node Pathology biopsy report

171

245

7.33

114.01

1.6

1.2

—

(3037756) Immunofixation for Serum or Plasma

275

621

4.76

113.69

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

225

432

5.54

112.16

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

313

795

4.27

111.38

1.3

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

1501

8972

2.32

110.74

6.0

2.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

672

2778

2.82

110.04

11.5

7.4

11.04

10.27

mmol/l

1.53

646

2660

(3016650) Hepatitis A virus Ab [Presence] in Serum

219

418

5.56

109.84

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

397

1206

3.63

109.63

2.1

2.4

4.07

4.18

g/l

1.36

370

1111

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

397

1206

3.63

109.63

2.1

2.4

6.60

7.43

g/l

16.95

370

1110

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

231

464

5.30

109.48

2.0

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

396

1205

3.62

109.05

2.1

2.4

3.62

3.76

g/l

0.55

369

1110

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1895

12550

2.33

108.76

4.6

3.1

331.89

130.69

ug/l

14.11

1808

11676

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

257

571

4.82

108.26

2.0

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

177

287

6.48

105.00

1.5

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

298

770

4.18

103.44

2.7

1.6

0.20

0.24

g/l

8.25

273

739

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

357

1049

3.72

103.38

2.2

2.5

0.86

1.12

g/l

0.46

302

904

(3008757) Leukocyte morphology finding [Identifier] in Blood

175

287

6.40

102.64

7.5

3.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

137

175

8.15

100.80

3.8

2.3

559.86

526.35

e6/l

0.17

139

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

300

795

4.07

100.55

2.7

1.6

1.10

1.19

g/l

4.32

281

761

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

369

1129

3.58

100.46

2.1

2.5

2.87

2.95

g/l

0.76

342

1034

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

196

368

5.62

99.96

1.4

1.2

6.36

3.22

u/ml

0.64

133

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

113

114

10.25

99.75

5.2

3.0

0.95

0.96

0.02

113

114

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

154

233

6.90

97.55

1.6

1.5

—

(3024471) HLA-A [Type]

12.70

96.90

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

170

289

6.17

96.14

2.5

12.30

40.44

iu/ml

2.18

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

150

225

6.96

95.77

1.5

1.9

4.51

4.65

mg/l

0.09

142

217

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

245

586

4.46

93.92

1.2

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1339

8019

2.19

93.76

4.4

3.5

0.47

0.41

e6/l

0.53

1069

5948

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

228

520

4.66

92.77

1.5

1.2

109.66

34.04

u/l

5.20

214

449

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

131

175

7.77

92.75

4.2

2.4

209.40

230.55

e6/l

0.32

150

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

291

800

3.91

92.48

2.2

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

1485

9295

2.16

92.46

4.6

3.6

108.97

82.59

e6/l

0.38

1219

7152

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

340

1045

3.53

91.63

2.0

2.5

10.69

10.35

g/l

0.56

312

943

(3018095) Leukocytes [#/volume] in Urine

1614

10476

2.14

90.91

5.5

4.2

109.24

101.39

e6/l

0.09

1256

7481

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1858

12728

2.16

90.89

6.2

2.8

—

estimate

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

543

2211

2.77

90.02

10.8

3.8

1.22

1.23

mmol/l

3.16

505

1909

(3007566) Smooth muscle Ab [Titer] in Serum

274

737

3.98

89.72

1.3

1.2

89.29

97.38

titre

0.18

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

306

889

3.71

89.72

2.0

2.4

0.02

g/l

0.12

274

800

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

138

204

7.03

89.26

1.2

1.3

80.67

84.75

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2594

20511

2.70

88.78

20.5

8.3

88.78

80.71

u/l

9.05

2542

19490

(36304419) Bacteria [Presence] in Urine

1276

7623

2.15

88.58

4.2

3.4

1.40

79.69

estimate

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

25.91

87.69

1.3

1.2

0.13

0.05

u/ml

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

247

626

4.20

87.68

1.7

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1054

5873

2.21

87.04

2.7

1.7

1.93

1.30

mg/l

5.75

892

4552

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

113

139

8.40

85.69

2.6

3.0

85.61

96.89

1.79

108

132

(3026782) Osmolality of Urine

1005

5542

2.21

84.75

3.8

3.0

505.91

538.39

mosm/kgh2o

5.42

931

4866

(3017354) Segmented neutrophils/Leukocytes in Blood

167

315

5.55

84.60

6.7

3.4

52.45

59.45

2.87

151

272

(3019309) Folate [Moles/volume] in Red Blood Cells

910

4823

2.26

84.58

2.1

1.8

1234.41

1166.25

nmol/l

1.26

734

3652

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

292

864

3.63

83.14

2.0

2.4

0.01

0.00

g/l

0.50

258

759

(3034770) Mitochondria Ab [Titer] in Serum

265

736

3.85

82.79

1.3

1.2

990.00

1179.00

titre

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

276

802

3.68

80.68

2.0

2.4

0.00

g/l

-0.00

258

758

(3042936) Bacteria identified in Isolate by Culture

793

4057

2.29

79.54

2.6

2.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

120

173

7.18

79.37

3.9

2.1

0.50

0.71

e9/l

2.32

110

163

(3036481) Cortisol [Moles/volume] in Serum or Plasma

578

2598

2.51

77.49

2.3

358.61

377.92

nmol/l

1.52

552

2402

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

168

357

4.92

74.27

1.5

1.2

5.08

3.48

u/ml

0.99

101

164

(3024932) HLA-DR beta [Type]

10.78

73.54

1.2

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2159

16307

2.09

73.53

10.4

5.4

6.68

6.77

mmol/l

1.07

2102

15515

(3000850) Epithelial cells [#/volume] in Urine

1087

6454

2.06

73.43

3.6

2.8

5.80

5.25

e6/l

0.66

1026

5896

(3000060) B lymphocytes [#/volume] in Blood

11.09

73.11

2.8

2.5

0.19

0.22

e9/l

0.15

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1755

12344

1.98

72.79

2.7

2.2

91.99

94.73

pmol/l

1.64

1142

6630

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

9.31

72.69

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

282

892

3.38

72.16

7.0

4.8

1.66

1.57

mg/l

0.85

263

808

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

608

2896

2.37

71.18

6.7

3.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

9.36

69.71

3.0

2.5

34.69

28.51

2.22

(3031040) Bacteria [#/volume] in Urine by Automated count

2274

17662

2.11

69.66

6.3

4.9

133.04

1401.58

e6/l

2.98

257

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1377

9016

1.96

69.35

6.2

3.2

41.09

36.84

u/l

0.90

1309

8522

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

289

953

3.24

69.04

3.8

2.9

0.29

0.35

iu/ml

2.19

170

505

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1339

8700

1.96

68.84

3.8

2.7

56.72

69.59

u/l

0.77

1254

8072

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

9.97

67.04

1.0

1.2

904.17

820.00

titre

0.16

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

12.75

66.71

1.6

1.4

—

(3006245) CD3-CD19+ cells/cells in Blood

8.77

65.51

3.0

2.6

10.36

9.40

0.24

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

296

1029

3.08

64.55

2.8

2.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

147

314

4.87

64.53

3.1

1.6

—

(40765096) Chromosome analysis panel by Banding

8.66

64.10

1.1

—

(1616796) Gas panel - Central venous blood

226

669

3.57

63.96

4.9

3.9

—

(40761536) Microorganisms panel - Urine sediment

485

2184

2.45

63.83

5.9

4.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

468

2077

2.48

63.56

10.5

9.7

24.13

24.87

mmol/l

4.23

461

2068

(3023420) DNA double strand Ab [Units/volume] in Serum

301

1069

3.01

63.19

2.7

1.7

9.18

7.46

iu/ml

0.42

250

(40758292) HTLV I+II Ab panel - Serum

13.35

62.27

1.4

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

268

901

3.16

61.82

1.7

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

18.42

61.25

1.1

1.0

—

(4268621) Lupus anticoagulant assay

128

257

5.15

60.37

2.6

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1401

9536

1.86

59.89

5.3

3.5

2.33

2.35

mmol/l

9.02

1307

8673

(3010421) pH of Blood

270

935

3.07

59.15

5.4

3.9

7.42

7.41

3.32

264

927

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1092

6891

1.91

58.93

5.6

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

133

283

4.87

58.62

3.4

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

369

1523

2.62

58.09

1.7

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

204

602

3.56

57.93

5.8

4.6

8.70

8.43

kpa

1.31

197

593

(3012501) Base excess in Blood by calculation

203

599

3.56

57.65

5.8

4.6

2.21

2.58

mmol/l

1.11

141

413

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

170

444

3.99

57.62

1.2

1.1

—

1.18

—

(3013290) Carbon dioxide [Partial pressure] in Blood

203

600

3.55

57.50

5.8

4.6

4.73

5.05

kpa

7.35

196

592

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

268

940

3.03

57.37

1.5

1.6

27.01

17.72

u/ml

0.69

200

(3026008) Bacteria identified in Urine by Culture

1255

8390

1.84

55.64

3.9

3.3

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2391

19517

2.02

55.51

6.8

4.4

16.52

12.43

mm/h

21.57

2281

18217

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

20.76

54.01

1.2

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

10.53

53.55

3.1

1.6

—

(3042631) Mycobacterium sp identified in Specimen

156

405

4.00

53.28

2.3

2.7

—

(3017732) Neutrophils [#/volume] in Blood

627

3382

2.07

52.32

5.0

3.3

7.17

4.54

e9/l

2.73

561

2914

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

159

6.00

52.15

3.2

2.7

34.53

40.79

1.67

(3021601) Nitrite [Presence] in Urine by Test strip

1860

14162

1.79

51.88

5.3

4.0

0.00

estimate

0.50

588

3059

(3035350) Ketones [Presence] in Urine by Test strip

1873

14345

1.78

50.62

5.3

4.0

4.20

3.07

estimate

0.14

598

3109

(3010375) cycloSPORINE [Mass/volume] in Blood

118

6.84

50.52

35.0

30.5

137.34

125.61

ug/l

0.62

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

436

2072

2.29

49.98

6.3

4.5

5.00

5.14

kpa

2.88

422

1989

(3009261) Glucose [Presence] in Urine by Test strip

1878

14424

1.78

49.95

5.4

4.0

0.01

0.12

estimate

0.52

565

2899

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

8.58

49.85

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

184

5.47

49.79

2.8

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

100

7.35

49.18

2.1

2.3

1685.67

32324.80

u/ml

—

(3021901) Oxygen saturation in Capillary blood

199

641

3.25

49.11

4.5

2.9

89.22

89.65

0.32

192

624

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1261

8688

1.77

48.69

4.2

3.2

1990.62

1488.14

ng/l

3.33

1140

7517

(3009343) pH of Capillary blood

424

2015

2.28

48.52

6.4

4.6

7.42

7.41

1.05

366

1674

(3028271) Lactate [Moles/volume] in Capillary blood

162

461

3.65

48.50

2.7

1.9

1.99

1.71

mmol/l

1.86

156

449

(3028626) Oxygen [Partial pressure] in Capillary blood

239

873

2.88

47.38

6.1

4.8

8.15

8.31

kpa

0.77

230

855

(3009445) Proteinase 3 Ab [Units/volume] in Serum

291

1181

2.62

47.06

1.4

1.5

6.32

18.10

iu/ml

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

100

7.14

46.62

1.1

—

(4212803) Bone marrow aspirate examination

17.47

46.30

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

203

686

3.10

46.19

2.0

11.49

12.04

mg/l

0.36

191

631

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

380

1775

2.30

45.13

6.4

4.5

1.80

1.71

mmol/l

0.19

285

1298

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

8.89

44.93

1.3

1.1

80.00

85.64

0.42

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

101

214

4.85

44.72

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

149

426

3.62

44.28

7.2

6.4

11.83

12.08

mg/l

0.26

140

400

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

393

1898

2.23

42.98

7.2

4.2

23.89

24.04

mmol/l

0.40

382

1876

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

10.59

42.88

1.5

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

141

397

3.67

42.86

2.0

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

141

397

3.67

42.86

2.0

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

141

397

3.67

42.86

2.0

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

141

397

3.67

42.86

2.0

1.5

—

(40758558) Short blood count panel - Blood

1182

8209

1.71

42.84

14.5

6.2

—

(3012544) pH of Venous blood

577

3234

1.97

42.34

6.8

4.1

7.38

0.01

358

1883

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

11.77

42.08

1.2

1.1

64.71

73.63

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

895

5774

1.78

41.99

1.9

1.8

473.37

29243739.01

pmol/l

4.59

768

4784

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

143

5.64

41.75

1.3

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

8.44

41.59

1.2

1.1

81.24

84.03

0.21

(3037692) Legionella sp identified in Specimen by Organism specific culture

7.05

41.54

1.3

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

570

3202

1.96

41.47

6.7

4.0

5.68

5.82

kpa

3.00

551

3114

(3022493) Free Hemoglobin [Mass/volume] in Plasma

117

6.19

41.31

2.8

2.4

165.13

60.83

mg/l

0.52

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

754

4643

1.83

41.24

4.1

3.3

2.30

1.96

e6/l

0.46

405

2323

(3002032) Base excess in Venous blood by calculation

555

3105

1.96

40.81

6.8

4.0

1.32

1.77

mmol/l

1.98

486

2667

(3024980) IgG subclass 4 [Mass/volume] in Serum

147

442

3.44

40.45

2.0

1.6

0.68

0.87

g/l

1.08

111

345

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

8.90

40.19

1.8

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.52

39.88

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

245

990

2.60

39.82

1.3

1.2

—

(3000991) Gas panel - Venous blood

498

2717

1.99

39.24

12.2

9.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

230

4.41

39.15

1.4

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

13.36

39.11

4.1

2.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

11.22

38.90

1.2

1.1

60.36

81.89

—

(3025941) Bacteria identified in Stool by Culture

306

1388

2.34

38.68

1.4

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1099

7642

1.68

38.63

1.8

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

499

2748

1.97

38.20

10.2

8.4

1.53

1.36

mmol/l

1.79

489

2700

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

111

289

3.95

37.74

1.2

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1418

10578

1.63

37.48

5.8

4.0

43.09

111.27

ng/l

0.97

1171

7738

(3015171) Extractable nuclear Ab [Units/volume] in Serum

235

961

2.56

37.22

1.4

1.2

0.97

0.82

u/ml

—

(3015736) pH of Urine

1503

11397

1.62

37.00

4.5

3.5

6.21

6.24

0.60

831

6339

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

101

249

4.16

36.98

3.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

101

249

4.16

36.98

3.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

101

249

4.16

36.98

3.6

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

571

3322

1.88

36.97

2.0

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

102

254

4.12

36.85

3.9

2.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

251

1071

2.46

36.32

5.2

3.1

23.98

24.71

mmol/l

1.92

243

1058

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

373

1891

2.11

35.74

2.2

1.7

—

(3000494) Fungus identified in Specimen by Culture

563

3299

1.86

35.51

2.1

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

119

5.65

35.03

1.3

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

196

762

2.68

34.35

1.4

1.3

21.30

15.15

iu/ml

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

473

2648

1.93

34.23

3.0

2.5

32.59

57.96

u/l

0.77

393

2221

(3006922) Hepatitis E virus Ab [Presence] in Serum

188

4.51

33.91

1.1

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

1116

7993

1.62

33.78

5.6

4.1

0.00

estimate

1.54

529

2790

(4062490) Immunoglobulin typing, IgG

101

267

3.88

33.63

1.6

1.3

—

(40768797) Stomach Pathology biopsy report

615

3761

1.79

33.55

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

139

5.13

33.44

4.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

139

5.13

33.44

4.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

139

5.13

33.44

4.4

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

139

5.13

33.44

4.4

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

250

1105

2.37

33.41

2.0

1.6

0.37

0.33

mg/l

0.34

110

516

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

123

373

3.39

33.39

1.2

1.1

1.58

1.51

g/l

0.70

117

343

(3028192) IgG subclass 2 [Mass/volume] in Serum

100

269

3.81

32.49

1.7

1.3

2.69

2.94

g/l

0.68

193

(3027135) IgG subclass 1 [Mass/volume] in Serum

100

269

3.81

32.49

1.7

1.3

6.47

6.79

g/l

0.34

193

(3024139) IgG subclass 3 [Mass/volume] in Serum

100

269

3.81

32.49

1.7

1.3

0.46

0.41

g/l

0.41

192

(3026250) Tacrolimus [Mass/volume] in Blood

118

5.43

32.11

35.7

38.9

7.10

6.95

ug/l

0.23

107

(3003396) Base excess in Arterial blood by calculation

569

3442

1.80

32.05

10.1

8.3

0.66

0.90

mmol/l

0.67

465

2825

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

253

1145

2.32

32.00

2.1

1.9

44.13

38.74

u/l

2.28

234

1009

(40768441) Liver Pathology biopsy report

189

4.37

31.88

2.1

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

825

5541

1.67

31.87

3.8

3.0

2.46

2.45

mmol/l

0.95

750

4982

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

105

5.71

31.76

5.0

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

765

5043

1.69

31.71

3.9

3.2

1.22

1.02

e6/l

0.44

418

2735

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

103

5.72

31.29

5.1

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

103

5.72

31.29

5.1

1.8

—

(3019977) pH of Arterial blood

570

3473

1.79

31.26

10.3

8.3

7.42

7.41

2.25

311

1897

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

569

3475

1.78

30.93

10.2

8.3

4.93

5.10

kpa

3.93

546

3337

(3027801) Oxygen [Partial pressure] in Arterial blood

568

3476

1.78

30.63

10.2

8.3

12.44

12.17

kpa

0.55

544

3341

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.20

30.52

2.9

1.8

3929.57

22546.88

e6/l

0.45

(3006184) Hemoglobin [Mass/volume] in Capillary blood

180

714

2.62

30.28

3.2

2.3

115.90

129.26

g/l

8.87

155

563

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1541

12102

1.55

30.25

3.1

2.5

75.56

77.21

nmol/l

1.51

1419

10872

(3019832) Treponema pallidum Ab [Presence] in Serum

399

2194

1.94

30.23

1.6

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

464

2686

1.86

30.01

6.0

3.5

4.72

4.59

kpa

0.67

445

2612

(3013139) Helicobacter pylori Ag [Presence] in Stool

338

1759

2.04

29.96

1.2

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

101

5.63

29.73

3.1

2.1

436.00

759.89

e6/l

1.08

(3041096) Erythrocytes [Presence] in Urine by Automated

1046

7568

1.58

29.32

5.3

3.4

0.01

0.14

estimate

0.67

491

2398

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.93

29.15

1.9

1.4

9.58

12.64

g/l

1.35

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

494

2947

1.81

28.89

4.0

4.3

17.77

22.68

ug/l

0.25

400

2420

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1164

8660

1.55

28.70

2.9

2.2

314.51

226.46

u/l

0.53

1106

8211

(3044007) Cell count panel - Peritoneal fluid

6.16

27.99

3.3

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

7.28

27.98

1.4

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

278

3.49

27.28

1.6

1.5

—

(3023419) Bacteria identified in Sputum by Culture

119

401

3.05

27.17

2.1

2.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

137

4.67

27.09

1.3

1.2

1.14

1.07

ratio

0.95

116

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

108

5.17

26.64

2.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

108

5.17

26.64

2.5

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

217

3.81

26.50

1.3

1.2

300.00

185.41

titre

0.36

(3016502) Oxygen saturation in Arterial blood

507

3121

1.75

26.45

10.6

8.6

95.28

95.54

0.35

487

3010

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2783

25521

1.96

26.17

42.8

17.0

24.71

25.35

mg/l

0.53

2581

21220

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

490

2996

1.76

26.15

2.2

1.8

1.71

1.51

3.95

408

2632

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

100

5.27

25.78

2.9

2.5

0.59

0.61

mmol/l

0.94

100

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

156

630

2.55

25.29

2.7

1.5

335.58

766.19

e6/l

0.83

130

494

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2019

17155

1.52

25.12

5.8

3.4

71.85

51.08

u/l

11.48

1917

16068

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

154

623

2.55

24.88

2.7

1.5

53.04

36.60

e6/l

0.14

120

461

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

223

1066

2.18

24.61

2.6

2.1

432.89

661.58

ug/l

0.53

212

1012

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2393

21157

1.59

24.38

52.3

20.8

14.59

13.68

101.97

2383

20874

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

179

788

2.35

24.06

2.3

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

160

4.13

23.91

2.4

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1349

10653

1.47

23.58

5.5

3.9

0.01

0.09

estimate

1.12

518

2545

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

169

732

2.38

23.56

1.5

1.2

3.31

3.33

u/ml

0.01

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

158

4.11

23.46

2.4

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

105

4.92

23.42

1.3

1.1

78.60

9.63

u/ml

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

175

778

2.32

23.00

1.5

1.2

35.12

39.90

u/ml

0.09

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

20.83

22.54

1.2

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

461

2881

1.71

22.50

11.7

9.1

112.50

121.63

g/l

15.74

451

2807

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

186

859

2.24

22.34

1.6

1.5

1.66

10.26

iu/ml

0.52

149

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

130

511

2.61

22.29

1.3

1.2

374.55

480.91

titre

0.16

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

118

442

2.74

22.25

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

371

2188

1.79

22.20

5.7

4.3

99.43

92.56

ng/l

0.65

322

1907

(3002331) Protein [Mass/volume] in Peritoneal fluid

5.97

22.14

1.5

1.3

14.25

24.89

g/l

4.10

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

166

735

2.33

22.02

1.5

1.2

16.51

7.79

u/ml

0.47

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

314

3.06

21.83

1.5

1.8

—

1505.45

—

(3044290) Cell count panel - Cerebral spinal fluid

141

583

2.49

21.77

2.9

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

318

3.02

21.36

2.7

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

336

2.95

21.15

2.3

1.61

1.40

g/24h

0.16

197

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

8.50

21.01

1.6

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

145

619

2.41

20.89

1.8

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

137

572

2.46

20.72

1.5

1.2

56.57

48.58

u/ml

0.22

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

160

719

2.29

20.51

2.6

1.4

611.50

577.85

mg/l

0.27

153

683

(3042733) HLA Ab [Presence] in Serum

5.06

20.43

3.2

4.8

—

(3022145) Colonoscopy Study observation

476

3083

1.64

20.11

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

220

3.37

20.10

1.6

1.3

2.46

2.18

mmol/l

0.39

206

(3014148) Varicella zoster virus Ab [Titer] in Serum

330

2.91

20.02

1.1

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

161

737

2.25

19.76

3.9

3.4

3.45

2.02

index

0.94

101

382

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

140

606

2.37

19.57

1.5

1.2

4.42

4.61

u/ml

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

19.50

19.48

2.3

5.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

101

375

2.75

19.40

1.3

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

321

2.89

19.22

4.8

6.1

8.34

7.35

mmol/l

0.31

273

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

313

1829

1.79

19.22

12.0

10.6

23.88

24.20

mmol/l

1.02

307

1790

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

22.68

19.04

1.2

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

144

640

2.31

18.95

2.6

1.3

3.74

3.78

mmol/l

0.12

133

602

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

816

6035

1.48

18.90

1.4

1.3

2.98

1.48

u/ml

1.31

197

1600

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

131

566

2.37

18.40

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

131

566

2.37

18.40

1.4

1.3

—

(4281824) Cell count and differential, peritoneal fluid

243

3.14

18.39

1.4

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

224

3.22

18.19

1.1

1.0

286.25

285.97

mg/l

0.01

203

(3022313) Gas panel - Capillary blood

258

1447

1.85

18.09

7.4

4.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

6.30

18.00

1.2

1.3

60.33

159.14

titre

—

(3003181) Sodium [Moles/volume] in Urine

128

553

2.37

17.98

1.8

1.4

63.50

61.34

mmol/l

0.19

442

(40768804) Tissue Pathology biopsy report

1300

10544

1.40

17.98

2.4

2.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

203

1055

1.99

17.89

3.6

3.4

611.08

4040.92

u/ml

0.73

170

916

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

140

632

2.27

17.78

3.8

3.4

295.33

795.90

u/ml

0.58

123

588

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

749

5508

1.48

17.67

4.7

4.1

427.75

630.57

ng/l

0.50

621

4435

(3003434) Protein [Mass/volume] in Pleural fluid

104

412

2.58

17.60

1.5

31.01

32.18

g/l

0.46

371

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

36.92

17.60

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.92

17.55

1.2

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

4.80

17.52

1.5

1.2

30.55

20.79

0.36

(3000570) Elastase.pancreatic [Mass/mass] in Stool

174

863

2.08

17.44

1.5

1.4

263.48

275.87

ug/g

0.33

521

(3024928) Oxygen saturation in Venous blood

163

794

2.11

17.14

5.7

3.2

63.68

61.43

0.63

154

770

(3039162) Centromere protein B Ab [Units/volume] in Serum

310

2.79

16.92

1.5

1.2

51.37

69.34

u/ml

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

209

3.20

16.83

1.1

—

(40760409) HLA-A [Type] by High resolution

40.29

16.32

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

40.29

16.32

1.1

1.0

—

(46236302) HLA-C [Type] by High resolution typing

40.29

16.32

1.1

1.0

—

(3013862) HLA-DP [Type]

40.29

16.32

1.1

1.0

—

(40763590) HLA-DQ beta [Type]

40.29

16.32

1.1

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

199

3.21

16.14

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

195

3.22

16.00

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

156

3.51

15.92

1.7

1.5

7.81

6.21

u/l

0.29

126

(3014051) Protein [Presence] in Urine by Test strip

962

7525

1.41

15.92

3.7

3.1

0.21

0.04

0.58

192

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

287

2.80

15.86

1.3

351.29

362.86

u/l

0.07

276

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

217

3.09

15.83

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

245

2.94

15.66

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

140

666

2.15

15.66

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

208

3.12

15.65

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

208

3.12

15.65

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2780

26120

1.68

15.53

44.2

20.4

139.16

139.65

mmol/l

17.52

2750

25617

(3012441) Differential panel - Pleural fluid

320

2.67

15.41

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2780

26157

1.66

14.98

45.4

20.6

3.99

mmol/l

0.03

2745

25610

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

204

3.08

14.87

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

31.84

14.79

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1777

15449

1.36

14.77

3.4

2.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

388

2.47

14.65

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

483

3364

1.52

14.58

2.6

2.5

154.64

138.08

ug/g

0.47

401

2690

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

202

1128

1.85

14.35

3.9

2.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

841

6586

1.38

13.36

4.3

3.8

0.00

0.11

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

130

3.50

13.32

1.7

1.4

66.40

69.20

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

260

1598

1.68

13.25

5.5

3.0

0.65

0.61

1.48

260

1589

(3004119) Hemoglobin [Mass/volume] in Venous blood

299

1907

1.63

13.20

5.8

3.3

115.22

129.03

g/l

17.63

291

1848

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

201

1150

1.80

13.20

8.0

5.2

24.86

24.68

mmol/l

0.45

190

1073

(3032057) Clostridioides difficile [Presence] in Stool

5.13

13.15

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

144

741

1.99

13.09

1.3

184.23

228.91

miu/ml

0.66

322

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

262

1621

1.67

13.02

5.7

3.0

1.28

1.20

0.86

262

1610

(3036782) Glucose [Moles/volume] in Pleural fluid

324

2.51

13.02

1.5

1.4

5.99

6.48

mmol/l

0.89

306

(21494890) Protein electrophoresis panel - 24 hour Urine

295

2.58

12.96

1.9

2.1

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

11.58

12.79

3.4

1.7

58.91

58.07

0.02

(3034426) Prothrombin time (PT)

4.51

12.59

1.2

31.47

28.01

1.11

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

299

1929

1.61

12.59

13.4

10.7

0.65

0.63

0.60

293

1918

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

20.10

12.44

1.3

1.1

—

(40768806) Pleura Pathology biopsy report

315

2.48

12.28

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

305

1999

1.58

12.01

12.8

10.4

1.44

1.30

1.29

299

1988

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2604

24376

1.45

11.91

38.0

16.7

78.12

79.53

ml/min/173m2

2.42

2484

22577

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

157

3.09

11.69

1.8

1.9

—

(3016750) Collection duration of Urine

163

3.04

11.60

2.3

2.1

522.09

502.05

min

0.51

116

(3017704) Immunofixation for Urine

174

2.96

11.56

1.9

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

279

1808

1.60

11.52

9.3

6.7

24.48

24.45

mmol/l

0.04

263

1726

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

180

1040

1.78

11.45

2.5

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

3.81

11.45

1.7

1.6

1991.11

3261.54

titre

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

154

3.08

11.42

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

345

2.35

11.40

1.1

1.2

104.66

113.91

1.29

314

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

5.40

11.34

2.8

3.2

48.57

22.61

mg/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

132

694

1.94

11.32

1.3

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

125

3.31

11.21

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

137

3.17

10.96

1.4

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

328

2.35

10.83

3.4

1.4

—

(3028433) Virus identified in Specimen by Culture

3.79

10.74

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

317

2.37

10.72

3.5

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

267

1743

1.58

10.68

15.1

11.0

14.83

15.98

8.39

258

1674

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.06

10.67

1.3

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

331

2.33

10.61

3.5

1.4

—

(4195642) Thrombophilia screening test

332

2.32

10.54

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

332

2.32

10.54

3.5

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

7.71

10.37

1.6

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

237

2.56

10.35

1.5

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2170

19871

1.31

10.32

4.7

4.3

14.94

14.84

pmol/l

1.04

2012

18142

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

317

2.33

10.27

3.6

1.4

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

10.61

10.26

3.7

1.6

13.00

21.91

—

(3018405) Lactate [Moles/volume] in Arterial blood

165

963

1.75

10.17

4.4

3.7

1.43

1.38

mmol/l

0.25

155

953

(3005988) Vibrio sp identified in Specimen by Organism specific culture

319

2.32

10.13

3.6

1.4

—

(3049717) Cytology report of Urine Cyto stain

190

1155

1.69

10.11

2.3

2.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

223

1414

1.62

10.07

2.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

343

2397

1.48

10.02

3.4

2.5

0.63

0.45

e6/l

0.73

336

2303

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.47

10.01

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.91

9.84

1.4

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

115

609

1.92

9.70

3.1

3.4

0.79

0.82

nmol/l

0.34

495

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.09

9.69

3.8

2.8

424.58

538.59

ug/l

0.07

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

13.39

9.66

1.1

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

372

2.18

9.60

1.5

1.4

1177.67

4014.91

e6/l

0.61

250

(3005322) IgE [Units/volume] in Serum or Plasma

258

1720

1.55

9.41

1.4

1.3

409.88

224.63

u/ml

1.08

223

1599

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

360

2.17

9.13

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

130

733

1.81

9.03

1.3

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

597

4680

1.34

8.93

1.3

44.10

33.24

iu/ml

0.58

186

1408

(3004775) Volume in Urine collected for unspecified duration

219

2.49

8.87

2.3

756.46

630.41

1.17

141

(3014765) Yersinia sp identified in Stool by Organism specific culture

130

739

1.79

8.80

1.3

1.1

—

(3002256) Pathology report gross observation

484

3688

1.37

8.68

1.4

1.3

—

(3037121) Protein [Mass/volume] in Urine

167

1027

1.66

8.54

3.6

3.7

367.92

384.06

mg/l

0.07

462

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

100

3.22

8.48

1.3

1.2

—

(3036603) Volume of Urine

200

2.52

8.47

1.5

1805.04

1910.86

0.38

195

(3026389) Candida sp identified in Specimen by Organism specific culture

339

2.15

8.42

1.3

1.4

—

(40768443) Skin Pathology biopsy report

187

1189

1.61

8.38

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

129

747

1.76

8.22

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

174

2.61

8.17

2.2

2.5

13.69

16.37

5.77

174

(3028308) Erythrocytes [#/volume] in Pleural fluid

325

2.15

8.07

1.4

57568.10

91172.34

e6/l

0.41

177

(40768446) Kidney Pathology biopsy report

114

3.00

8.03

1.8

—

(3035880) pH of Pleural fluid

170

2.61

8.01

1.5

1.3

7.41

7.40

0.10

119

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2785

26741

1.44

7.93

27.1

12.3

27.45

26.17

u/l

1.81

2745

25943

(3008295) Osmolality of Serum or Plasma

335

2.11

7.88

1.7

1.4

279.88

277.52

mosm/kgh2o

0.30

246

(3045414) Leukocytes [Presence] in Urine

360

2660

1.40

7.75

2.5

2.1

0.00

0.01

estimate

0.78

552

(3035947) Staphylolysin Ab [Units/volume] in Serum

128

2.83

7.68

1.1

—

5.29

iu/ml

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.43

7.66

1.4

1.3

—

(3045788) Cell count panel - Pleural fluid

313

2.13

7.61

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

256

2.25

7.52

4.1

3.5

11.27

11.44

index

0.04

151

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

304

2195

1.43

7.46

3.4

2.9

59.01

64.77

ml/min/173m2

1.67

161

939

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

125

2.82

7.42

1.1

1172.50

1444.23

miu/ml

0.87

125

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

142

2.70

7.41

1.6

1.86

2.52

u/field

0.29

103

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

160

2.58

7.34

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.37

7.31

1.3

1.4

1.38

1.03

iu/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

204

1374

1.52

7.14

5.3

3.3

24.64

25.23

mmol/l

1.73

198

1321

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

117

2.84

7.10

1.1

361.00

197.35

iu/ml

0.74

117

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

6.57

7.10

2.1

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

121

719

1.71

7.09

1.6

1.5

12.84

8.83

u/l

1.83

581

(3046861) Legionella sp Ag [Presence] in Urine

8.78

7.04

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2803

27023

1.43

7.03

49.5

22.2

86.13

79.97

umol/l

9.16

2782

26706

(3004451) EKG impression Narrative

170

2.49

7.00

1.4

1.3

—

(3000330) Specific gravity of Urine by Test strip

207

1405

1.51

6.99

4.2

3.4

1.02

ratio

0.41

197

1281

(36660697) Celiac disease serology panel - Serum

290

2107

1.42

6.88

1.2

—

(3019225) pH of Specimen

355

2675

1.37

6.78

8.6

4.4

7.37

7.36

0.94

300

1918

(3020191) Ethanol [Moles/volume] in Serum or Plasma

211

2.29

6.69

2.0

1.4

1.15

1.17

promille

0.04

166

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

220

2.25

6.51

1.2

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2490

23650

1.28

6.48

5.9

5.3

2.00

1.95

mu/l

1.10

2339

21802

(3016038) Potassium [Moles/volume] in Urine

202

2.30

6.44

2.3

1.3

31.40

34.95

mmol/l

0.47

180

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

9.26

6.28

3.5

4.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

195

1341

1.48

6.20

7.8

5.1

1.63

1.59

0.28

182

1259

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

166

2437

0.66

6.20

2.1

2.0

3.57

3.48

ratio

0.35

127

1905

(3034274) Bile acid [Moles/volume] in Serum --fasting

293

2.03

6.10

2.1

2.5

10.85

9.63

umol/l

0.16

206

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

260

2.10

6.06

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

301

2.01

6.04

4.5

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

350

1.93

6.02

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

179

1220

1.50

5.96

8.7

5.4

0.85

0.87

0.35

169

1145

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

7.25

5.92

1.7

1.4

0.89

1.58

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

7.25

5.92

1.7

1.4

3.37

1.70

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.25

5.92

1.7

1.4

1.54

2.86

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.25

5.92

1.7

1.4

1.65

4.74

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

7.25

5.92

1.7

1.4

0.15

0.54

mg/l

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

112

2.69

5.91

3.2

1.7

37.44

40.03

g/l

1.04

112

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

187

2.26

5.73

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

6.86

5.73

1.7

1.5

2.64

3.05

mg/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.89

5.61

1.1

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

317

1.94

5.59

3.8

2.5

1.20

1.19

mmol/l

0.15

312

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

12.89

5.58

1.0

—

(3013512) EKG study

1072

9450

1.21

5.57

4.7

3.8

—

0.68

—

(3045424) Erythrocytes [Presence] in Urine

194

1363

1.45

5.56

2.7

2.2

0.02

0.62

estimate

0.49

408

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

6.52

5.55

1.1

1.3

1.90

0.76

ml/s/173m2

—

(3052592) Norovirus Ag [Presence] in Stool

3.82

5.53

1.8

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.82

5.53

1.2

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

305

2318

1.35

5.52

3.5

3.0

287.67

209.38

ng/l

2.15

284

2127

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

119

754

1.60

5.51

1.5

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.86

5.51

3.3

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

3.63

5.48

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

179

2.25

5.41

2.5

2.2

7.92

8.25

mmol/l

0.20

179

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.02

5.24

1.3

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

138

916

1.53

5.24

1.6

1.7

—

(3041354) Potassium [Moles/volume] in Venous blood

325

1.89

5.22

3.8

2.4

4.05

4.08

mmol/l

0.25

320

(3035285) Chloride [Moles/volume] in Venous blood

325

1.89

5.22

3.8

2.4

105.95

105.51

mmol/l

0.35

320

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

318

2453

1.33

5.21

2.3

2.4

10.28

7.55

ug/l

0.90

277

2167

(3028679) Herpes simplex virus Ab [Presence] in Serum

132

2.44

5.20

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

145

2.36

5.15

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.86

5.11

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

165

2.26

5.07

1.3

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

8.35

5.05

3.0

4.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

185

2.18

5.03

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

10.02

5.02

2.6

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

175

1231

1.45

5.01

1.2

1.1

177.50

135.84

titre

—

(1761482) Bacteria [#/volume] in Urine by Culture

106

670

1.60

4.99

4.9

4.3

—

(3044927) Protein electrophoresis panel - Urine

302

1.90

4.97

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

325

1.86

4.90

1.5

1.2

—

(3014271) Vancomycin [Susceptibility]

136

2.37

4.90

3.3

2.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

131

2.38

4.81

1.5

1.7

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

6.49

4.77

1.1

5.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

960

10786

0.84

4.71

2.2

1.9

1.43

1.35

mmol/l

1.61

792

9061

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

526

4384

1.24

4.66

1.3

16.99

11.33

u/ml

0.65

164

1651

(3020682) Albumin/Creatinine [Ratio] in Urine

1048

9335

1.19

4.66

5.1

4.2

12.21

10.43

mg/mmol

0.33

709

5970

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

303

1.86

4.61

3.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.53

4.55

1.1

1.3

22.54

18.89

u/l

—

(3009508) Creatinine [Moles/volume] in Urine

1086

9728

1.18

4.48

4.3

3.5

7.13

7.66

mmol/l

3.60

932

8222

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.28

4.46

1.8

1.6

4.09

9.48

1.39

(3010838) Calcium [Moles/time] in 24 hour Urine

448

1.69

4.44

1.8

1.9

4.37

4.83

mmol/24h

0.57

395

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.52

4.35

2.6

1.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

124

1791

0.68

4.31

1.8

3.38

3.45

mmol/l

0.31

1258

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

2.18

4.24

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

114

764

1.51

4.21

2.5

2.3

6678.24

5642.88

u/l

0.11

316

(3043409) Potassium [Moles/volume] in Arterial blood

117

790

1.50

4.17

4.9

3.9

3.87

3.93

mmol/l

0.54

111

784

(3035637) Corticotropin [Mass/volume] in Plasma

366

1.74

4.14

1.5

1.6

23.23

27.97

ng/l

0.60

366

(3003329) Lymphocytes/Leukocytes in Synovial fluid

236

1.92

4.10

1.7

1.5

29.14

27.93

0.08

141

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

161

1160

1.41

4.09

7.7

3.4

74.00

70.99

u/ml

0.05

156

1120

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

266

1.86

4.04

1.3

1.1

57.33

51.47

u/ml

—

(3012516) Albumin [Mass/volume] in Urine

1020

9151

1.17

4.03

4.0

3.6

66.32

47.87

mg/l

1.81

724

6022

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

117

2.32

4.01

1.3

1.1

1721.42

215.40

ng/l

0.62

(3047181) Lactate [Moles/volume] in Blood

125

866

1.46

3.94

9.7

6.1

1.37

1.34

mmol/l

0.15

756

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.64

3.89

1.5

1.4

9.67

9.11

ug/l

0.20

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.29

3.86

6.4

6.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

7.29

3.86

1.8

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

205

1553

1.34

3.85

3.5

4.24

4.48

pmol/l

2.46

188

1376

(3006571) Granulocytes/Leukocytes in Synovial fluid

309

1.76

3.77

1.7

1.6

62.31

61.36

0.06

191

(3010813) Leukocytes [#/volume] in Blood

2829

27634

1.30

3.73

64.3

25.7

6.42

6.82

e9/l

5.39

2788

26959

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2828

27625

1.30

3.71

64.2

25.6

92.39

91.20

25.17

2808

27312

(3035941) MCH [Entitic mass]

2828

27627

1.30

3.69

64.1

25.5

30.66

30.36

11.56

2808

27312

(3004716) Salmonella sp identified in Stool by Organism specific culture

167

1234

1.37

3.69

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

2828

27628

1.30

3.68

64.3

25.6

4.14

4.48

e12/l

132.43

2785

26957

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2828

27628

1.30

3.68

65.6

26.2

37.52

40.38

45.36

2808

27301

(3007461) Platelets [#/volume] in Blood

2827

27619

1.29

3.67

64.5

25.7

162.85

247.68

e9/l

307.65

2786

27038

(3000963) Hemoglobin [Mass/volume] in Blood

2828

27634

1.29

3.63

64.9

25.8

124.70

134.85

g/l

153.83

2809

27326

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.48

3.62

1.2

1.3

357.04

112.93

ug/l

0.29

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

136

2.14

3.60

2.7

2.0

29.28

27.08

umol/l

0.38

125

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

7.79

3.56

2.4

4.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

141

1022

1.40

3.51

1.5

1.4

30.01

25.81

iu/l

0.65

111

858

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.42

3.46

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

2.42

3.46

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.42

3.46

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.42

3.46

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

106

2.27

3.45

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

208

1.89

3.44

1.2

1.1

61.11

41.50

mg/l

1.13

171

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

2.31

3.42

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

143

1929

0.73

3.40

1.3

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.01

3.37

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.01

3.37

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

629

0.54

3.36

1.4

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

103

714

1.46

3.29

1.8

1.6

18326.65

14211.70

e6/l

0.40

489

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

102

2.26

3.28

1.1

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

3.03

3.25

1.9

2.9

—

(44806071) Cardiolipin IgM antibody measurement

3.80

3.18

1.1

1.0

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

153

1.97

3.04

1.5

1.2

0.46

0.54

ratio

1.19

(3013945) Hepatitis B virus e Ab [Presence] in Serum

5.84

3.02

1.9

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

751

0.61

2.92

1.1

0.57

0.64

ratio

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

213

1694

1.28

2.87

1.2

147.55

144.66

u/ml

0.04

615

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

201

1.80

2.81

1.1

361.90

280.80

mg/l

0.70

174

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

151

1.93

2.79

3.3

3.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

254

1.70

2.77

1.4

1.6

3.42

4.31

ug/l

0.38

225

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

239

1.72

2.77

2.7

2.1

1.77

1.66

u/field

0.05

129

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.92

2.77

1.1

—

(3006270) Folate [Moles/volume] in Blood

202

1.79

2.77

1.3

1.2

335.26

363.20

nmol/l

0.33

174

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

8.34

2.75

1.0

—

(3019174) dRVVT (LA screen)

4.22

2.67

1.4

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.22

2.67

1.1

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

3.76

2.67

1.1

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.18

2.67

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

220

1.74

2.64

1.2

104.66

104.17

pmol/l

0.02

220

(40765089) Chromosome analysis panel - Blood by G-banded

2.30

2.57

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.61

2.57

1.4

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.23

2.53

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

250

2059

1.23

2.52

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

129

1.95

2.50

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.13

2.43

1.6

—

(4211845) Urine protein measurement

131

1.92

2.40

2.7

3.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.83

2.34

1.5

1.2

—

(3014891) Appearance of Pleural fluid

2.76

2.27

1.4

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.89

2.25

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

489

4322

1.16

2.25

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

392

1.49

2.21

6.5

5.4

405.46

353.99

umol/l

1.67

353

(3022621) pH of Urine by Test strip

258

2164

1.21

2.21

2.7

6.07

0.00

196

1489

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.86

2.20

1.3

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.34

2.18

9.0

4.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

4.29

2.15

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

3.69

2.15

1.4

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

227

1.64

2.14

1.5

23.44

21.65

u/ml

—

(40757373) Influenza virus identified in Isolate

2.37

2.12

1.3

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.26

2.07

1.1

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

198

1629

1.23

2.06

1.4

1.3

64.85

56.36

au/ml

0.19

111

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.50

2.05

1.7

1.4

8599.71

3730.92

ng/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

661

1.36

2.04

2.8

2.3

173.25

104.65

ug/min

0.80

406

(3039000) Anion gap in Blood by calculation

593

1.38

2.03

12.5

7.1

11.03

11.29

mmol/l

0.32

523

(3018572) Chloride [Moles/volume] in Blood

594

1.37

2.01

12.5

7.1

105.29

105.28

mmol/l

0.00

524

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.50

2.01

2.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.50

2.01

2.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.50

2.01

2.4

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.96

2.00

2.7

2.5

171.09

103.39

ug/l

0.15

(3023511) Choriogonadotropin [Units/volume] in Urine

386

1.46

1.97

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.75

1.93

2.2

2.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

272

3165

0.85

1.91

12.9

7.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.96

1.89

6.3

2.6

10.04

10.29

kpa

0.18

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.96

1.89

6.3

2.6

4.98

4.93

kpa

0.05

(3001019) Free T4 and TSH panel - Serum or Plasma

1066

0.74

1.88

1.8

1.7

—

(3006462) Nitrate [Presence] in Urine

121

1.82

1.88

2.9

3.5

—

(3028707) Methadone [Presence] in Urine by Screen method

391

1.44

1.86

8.8

2.5

—

(3042517) Benzodiazepines panel - Urine

3.53

1.83

1.2

2.2

—

(4198724) Urine methamphetamine measurement

1.92

1.80

2.1

2.0

—

(3026480) Teichoate Ab [Titer] in Serum

3.05

1.80

1.3

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

124

1.78

1.75

1.1

—

(3020650) Glucose [Presence] in Urine

1.90

1.75

1.3

1.8

0.00

0.06

estimate

0.80

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.85

1.71

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.85

1.71

11.4

11.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

194

1.60

1.71

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.14

1.71

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

210

1.58

1.70

2.8

2.7

21.35

32.30

mg/l

1.54

153

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.00

1.69

2.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

687

6321

1.11

1.67

5.4

4.1

1.02

1.25

kg/l

0.50

503

4249

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.16

1.66

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.00

1.58

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.70

1.58

1.0

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.28

1.55

10.4

11.9

9.27

5.87

mmol/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

579

1.32

1.54

4.6

3.6

30.64

29.17

mg/l

0.13

405

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.43

1.53

1.8

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

209

1786

1.18

1.53

2.7

2.4

33.23

20.14

au/ml

0.47

166

(3006653) Thiamine [Moles/volume] in Blood

146

1.65

1.50

1.0

1.3

127.21

138.23

nmol/l

0.39

146

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

162

1.61

1.49

1.1

1.24

1.18

u/l

0.19

(40762887) Creatinine [Moles/volume] in Blood

3.13

1.44

2.0

1.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.86

1.40

1.2

9.11

8.97

pmol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

263

1.45

1.38

1.2

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

881

0.77

1.38

2.1

1.7

9.67

4.51

mg/l

0.76

647

(3039443) Prostate specific Ag panel - Serum or Plasma

515

0.70

1.37

1.8

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

697

1.27

1.37

1.2

1.1

1.58

3.67

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.61

1.36

1.3

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.61

1.36

1.0

1.1

—

23.57

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

257

1.44

1.33

1.2

—

(3001729) Color of Synovial fluid

2.50

1.30

1.7

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

106

1.70

1.29

1.3

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.36

1.29

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.36

1.29

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

456

1.32

1.28

1.2

1.1

3.52

18.09

au/ml

—

100

(3030313) Adrenal Ab [Titer] in Serum

2.78

1.28

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.89

1.28

9.2

6.2

6.53

5.35

kpa

0.69

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

777

8272

0.92

1.27

4.3

4.7

23.48

21.94

1.76

378

4236

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.72

1.27

1.4

2.8

1.19

1.41

ug/l

0.27

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.40

1.24

1.3

1.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

516

1.28

1.17

1.7

2.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

102

1.67

1.16

1.9

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.50

1.15

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

386

1.33

1.15

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

395

1.32

1.14

1.5

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

142

1.55

1.14

2.4

2.7

47.60

48.75

umol/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

510

1.28

1.13

1.4

1.5

70.80

63.12

ug/l

0.32

436

(3005033) Fetal Nuchal fold Thickness US

379

1.32

1.12

1.4

1.5

1.20

1.29

0.76

278

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.38

1.09

1.0

1.2

334.20

353.57

umol/24h

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

355

1.33

1.08

1.7

1.4

0.95

0.34

nmol/l

0.60

275

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.19

1.08

1.0

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.69

1.07

2.7

3.9

9.15

8.19

mg/l

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.87

1.07

3.3

2.3

7.90

7.92

mmol/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.12

1.05

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

137

1.54

1.05

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

106

892

1.19

1.00

1.5

1.6

1078.49

1019.09

mu/l

0.23

754

(3033099) Centromere Ab [Titer] in Serum

1.88

1.00

1.4

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1076

10303

1.07

0.99

5.4

5.8

3.36

3.48

ug/l

0.06

942

9296

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

648

1.22

0.98

1.1

1.00

6.92

eliau/ml

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

585

1.24

0.97

1.8

1.00

0.86

nmol/l

0.86

480

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.95

0.97

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.95

0.97

1.0

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.85

0.96

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

452

1.27

0.95

1.4

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.22

0.93

2.3

2.9

0.00

0.67

u/field

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

365

1.29

0.92

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

476

0.75

0.92

1.1

0.81

1.44

u/ml

0.56

228

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

207

2312

0.89

0.92

1.9

2.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

720

0.80

0.91

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.07

0.89

2.0

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.07

0.89

3.2

2.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

255

1.34

0.86

1.2

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.82

0.85

2.8

2.9

47.75

41.86

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.82

0.85

5.5

5.8

10.00

8.20

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.85

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

451

1.25

0.84

1.4

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.57

0.84

1.1

69.44

92.38

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.76

0.83

1.1

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.76

0.83

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

300

3263

0.91

0.83

4.6

5.0

31.57

32.48

0.70

217

2135

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

381

1.26

0.82

1.9

1.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.69

0.82

1.3

1.6

0.38

0.48

e9/l

0.76

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

180

1.39

0.81

1.0

1.1

13.76

16.27

u/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.73

0.79

1.9

1.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

139

1.44

0.79

3.4

2.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.79

0.0

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

844

1.17

0.76

1.7

375.04

297.84

mu/l

0.78

772

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

332

1.27

0.76

1.0

1.1

9.31

2.64

eliau/ml

0.40

131

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

124

1.45

0.75

1.4

3.1

66.18

122.29

umol/l

1.27

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.00

0.72

2.4

3.2

0.84

0.61

ug/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

343

0.76

0.70

1.0

0.16

0.28

u/ml

—

130

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2441

24705

0.94

0.69

5.2

5.1

1.35

1.44

mmol/l

18.61

2225

22852

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2498

25263

0.94

0.69

5.9

2.47

2.64

mmol/l

17.98

2292

23429

(3003888) Timothy IgE Ab [Units/volume] in Serum

486

0.80

0.68

1.1

1.89

4.66

u/ml

2.53

278

(40768800) Prostate Pathology biopsy report

691

0.84

0.66

1.1

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

223

1.30

0.66

1.4

0.94

3.13

u/ml

1.24

127

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

430

1.21

0.66

2.0

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

111

1.44

0.65

1.3

148.88

170.28

mmol/24h

0.49

111

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.72

0.64

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.72

0.64

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.72

0.64

1.0

1.2

1.62

1.94

umol/24h

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

880

0.86

0.63

1.9

49.41

41.91

nmol/l

1.51

847

(3011288) Drugs identified in Urine by Screen method Nominal

618

1.17

0.62

13.3

2.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.55

0.62

1.0

1.1

—

(3024263) Appearance of Synovial fluid

147

1.36

0.61

2.0

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

564

0.83

0.60

1.2

1.1

0.78

2.79

u/ml

3.33

322

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

234

2524

0.92

0.58

2.0

2.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.51

0.58

1.8

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

716

1.15

0.58

1.5

1.4

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

115

1.39

0.56

1.2

13.81

9.47

mm/h

0.45

115

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

107

1.40

0.55

4.5

1.9

35.80

878.63

pmol/l

—

(3016879) Cocaine [Presence] in Urine

842

1.13

0.55

5.7

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

107

1190

0.90

0.52

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

229

2456

0.93

0.51

1.6

1.5

—

(4034850) Laboratory test

810

0.87

0.51

22.4

10.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2468

24444

1.05

0.48

5.9

5.3

6.08

5.98

mmol/l

2.29

2272

22337

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.45

0.48

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.49

0.47

8.7

7.6

9.79

10.66

—

(40768793) Breast Pathology biopsy report

554

1.14

0.44

1.4

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.56

0.42

1.2

1.1

48.60

69.28

ug/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.38

0.41

1.0

1.1

26.26

38.32

iu/ml

—

(3000764) Benzodiazepines [Presence] in Urine

900

1.10

0.41

5.5

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

131

1417

0.92

0.40

2.1

—

(1002224) Polysomnography panel

102

1115

0.91

0.39

1.1

—

(4015189) Microbial culture of sputum

1.41

0.39

2.5

2.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.39

0.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

475

1.14

0.39

1.4

1.5

1.23

1.18

ratio

0.17

300

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

475

1.14

0.39

1.4

1.5

1.50

1.22

ratio

1.07

301

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

475

1.14

0.39

1.4

1.5

0.92

0.96

ratio

0.33

300

(3010726) Horse dander IgE Ab [Units/volume] in Serum

463

0.86

0.38

1.1

0.73

1.78

u/ml

1.50

254

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.39

0.38

1.2

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.36

0.36

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

469

1.13

0.36

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

235

1.19

0.36

5.0

5.2

33.57

34.36

u/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

179

0.78

0.35

1.6

1.4

132.36

213.87

pmol/l

0.76

179

(3028300) Cannabinoids [Presence] in Urine

909

1.09

0.35

5.6

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

384

0.86

0.35

1.0

1.1

6.13

3.91

u/ml

0.16

205

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

146

1.23

0.32

7.1

7.0

4.04

141.90

ug/l

—

(3027008) Opiates [Presence] in Urine

905

1.09

0.32

5.6

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

714

1.09

0.31

6.6

2.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

193

1.19

0.30

1.0

1.1

8.72

8.98

iu/ml

—

(3020491) Glucose [Moles/volume] in Blood

184

1.20

0.30

1.7

2.1

6.43

6.85

mmol/l

0.31

122

(3050129) First trimester maternal screen panel - Serum or Plasma

591

1.10

0.30

1.3

1.4

—

(3008898) HLA-B27 [Presence]

825

0.92

0.28

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.32

0.28

1.9

1.4

9.33

8.67

mmol/l

—

(3027944) Amphetamines [Presence] in Urine

894

1.08

0.27

5.6

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

322

3335

0.96

0.27

1.7

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

328

1.13

0.26

1.6

1.3

0.21

0.19

nmol/l

0.53

262

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

376

1.12

0.26

1.6

1.4

0.65

5.38

nmol/l

0.50

359

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

443

1.11

0.26

1.1

1.60

122.71

iu/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2377

23616

1.03

0.26

4.7

4.4

1.32

1.28

mmol/l

1.84

2173

21620

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2474

24872

0.97

0.25

5.4

5.2

4.28

4.53

mmol/l

25.87

2273

23171

(3020874) Milk IgE Ab [Units/volume] in Serum

157

0.83

0.22

1.0

1.1

11.43

1.42

u/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

124

0.81

0.21

1.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.28

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

0.16

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.04

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.77

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.18

0.19

2.3

2.2

—

(4024509) Urine culture

133

1272

1.05

0.19

2.3

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

147

1.16

0.18

1.2

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.22

0.17

1.7

1.5

81.50

490.44

nmol/24h

—

(37021550) Renin [Units/volume] in Plasma --upright

1.11

0.17

1.4

103.64

55.46

mu/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

360

0.92

0.16

1.0

1.1

3.20

5.00

u/ml

0.46

174

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

264

1.10

0.15

2.1

1.6

389.83

324.82

mu/l

0.34

213

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

604

6123

0.98

0.13

3.2

3.4

0.89

0.78

ug/l

0.61

422

4162

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2103

21121

0.99

0.13

50.2

21.8

331.41

332.36

g/l

4.29

2090

20989

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

317

1.07

0.12

1.6

1.3

—

nmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

328

1.07

0.11

1.5

1.6

49.33

56.37

ug/l

0.65

328

(44813793) Dust mix specific IgE antibody measurement

173

1.10

0.10

1.1

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

193

1.09

0.09

2.0

1.5

98.71

84.73

umol/l

0.85

193

(3011897) Casein IgE Ab [Units/volume] in Serum

1.04

0.09

1.2

1.5

0.02

1.60

u/ml

—

(3025130) Human papilloma virus identified in Specimen

311

1.06

0.09

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

716

1.03

0.08

2.2

2.0

15.28

11.88

iu/l

0.09

291

(42870560) Thyrotropin [Units/volume] in Cord blood

0.86

0.07

1.0

10.55

9.24

mu/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.08

0.07

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.07

0.07

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

225

1.07

0.07

3.3

3.2

13.28

35.39

mg/l

1.59

169

(3025018) Bordetella pertussis Ab [Titer] in Serum

186

1.08

0.07

1.2

—

(1761868) Lipid panel - Serum or Plasma

927

9318

0.99

0.06

3.5

3.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2406

24012

1.01

0.06

7.2

6.6

39.17

39.57

mmol/mol

1.33

2235

22391

(3014599) Egg white IgE Ab [Units/volume] in Serum

152

0.92

0.06

1.0

1.2

3.45

2.22

u/ml

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

203

0.94

0.06

1.0

38.75

42.74

ng/l

0.21

129

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

203

0.94

0.06

1.0

702.43

692.05

ng/l

0.03

131

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

148

1.08

0.06

1.6

2.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

202

0.94

0.05

1.0

253.64

308.64

ng/l

0.51

133

(44806420) Estimation of glomerular filtration rate

279

1.04

0.04

2.1

2.4

—

(4146454) Self-monitoring of blood glucose

311

0.96

0.03

3.0

2.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

429

1.03

0.03

1.5

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

281

1.03

0.02

1.1

1.2

—

28.80

—

(1617658) Protocol used for examination of sentinel lymph nodes

172

1.05

0.02

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

351

1.03

0.02

2.1

2.2

15.18

20.73

mg/l

0.51

126

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

134

1332

1.01

0.01

1.1

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

164

1.04

0.00

2.7

1.9

119.18

123.05

ng/l

0.06

164

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

116

1.03

0.00

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

295

1.02

0.00

1.5

1.3

7.65

7.49

mmol/l

0.09

259

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

260

1.00

0.00

1.2

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

251

2510

1.00

0.00

2.3

12.60

13.01

nmol/l

0.28

222

2256

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.89

0.00

1.0

1.1

85.22

56.05

u/ml

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.89

0.00

1.0

1.1

0.38

5.93

u/ml

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3220.00

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.5

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

8.45

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.96

-0.00

1.6

2.2

9.98

16.71

umol/l

—

(4133840) Spirometry

1.02

-0.00

1.0

1.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

26.50

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.5

—

46.92

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.96

-0.00

2.4

2.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint D3_THROMBOCYTOPENIANAS and mortality.

Females

Parameter	HR [95% CI]	p-value
D3_THROMBOCYTOPENIANAS	2.959 [2.61, 3.36]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.239

During the follow-up period (1.1.1998 — 31.12.2019), 2428 out of 7148 females with D3_THROMBOCYTOPENIANAS died.

Males

Parameter	HR [95% CI]	p-value
D3_THROMBOCYTOPENIANAS	3.095 [2.72, 3.52]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.474

During the follow-up period (1.1.1998 — 31.12.2019), 3444 out of 8372 males with D3_THROMBOCYTOPENIANAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_THROMBOCYTOPENIANAS.

N-year risk	Females	Males
1	0.242%	0.6%
5	1.655%	4.353%
10	4.4%	10.977%
15	8.294%	19.863%
20	14.628%	32.578%

Relationships between endpoints

↥

Index endpoint: D3_THROMBOCYTOPENIANAS – Thrombocytopenia, unspecified

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Thrombocytopenia, unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints